Other and unspecified nerve root and plexus disorders, also in other diseases

G6_ROOTPLEXOTHUNS

peripheral nervous system disease: A disease involving the peripheral nervous system.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — G54.8, G54.9, G55* Hospital discharge: ICD-9 — 353[8-9] Cause of death: ICD-10 — G54.8, G54.9, G55* Cause of death: ICD-9 — 353[8-9] 2 out of 7 registries used, show all original rules.	11188
4. Check minimum number of events None	11188
5. Include endpoints None	11188
6. Filter based on genotype QC (FinnGen only)	10046

Control definitions (FinnGen only)

Control exclude: G6_NERPLEX

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	G6_ROOTPLEXOTHUNS
CONTROL_EXCLUDE	G6_NERPLEX
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G54[8-9]\|G55
HD_ICD_9	353[8-9]
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G54[8-9]\|G55
COD_ICD_9	353[8-9]
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other and unspecified nerve root and plexus disorders, also in other diseases based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	45171	22065	22893
Only index persons	43174	21254	21920
Unadjusted period prevalence (%)
Whole population	0.63	0.63	0.64
Only index persons	0.81	0.78	0.84
Median age at first event (years)
Whole population	52.39	53.19	51.68
Only index persons	51.98	52.71	51.27

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	10046	5653	4393
Unadjusted period prevalence (%)	2.01	2.01	2.01
Median age at first event (years)	55.80	54.51	57.46

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
10423: Matched controls
104230

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

ACC53

NOMESCO Finland

Release of ulnar nerve

137.1

322.6

162

M75.1

ICD-10 Finland

Rotator cuff syndrome

2.3

317.6

3277

17139

WX408

NOMESCO Finland

General anesthesy, balanced

2.3

313.8

3242

16951

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.3

313.2

3307

17449

M01AB05

ATC

diclofenac; systemic, rectal

2.3

309.7

7617

56126

ABC30

NOMESCO Finland

Decompression of cervical nerve roots

12.6

309.4

304

247

NA3BG, ,

SPAT

4.9

307.7

986

2172

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

3.2

307.7

2537

9409

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

20.5

307.7

2222

1360

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

5.4

307.7

2482

5743

M03BX02

ATC

tizanidine; oral

3.2

307.7

7983

53021

N02AX02

ATC

tramadol; systemic, rectal

4.1

307.7

6612

30782

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

6.9

307.7

1628

2735

WX402

NOMESCO Finland

General anaesthesia

2.4

307.7

3156

16059

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

9.1

307.7

717

842

G54.0

ICD-10 Finland

Brachial plexus disorders

19.6

307.7

488

261

N03AX12

ATC

[U] gabapentin; oral

8.8

307.7

4370

7866

M01AH05

ATC

etoricoxib; oral

2.9

307.7

7865

53663

M48.0

ICD-10 Finland

Spinal stenosis

8.3

307.7

3179

5261

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

286.1

307.7

3170

159

G54.9

ICD-10 Finland

Nerve root and plexus disorder, unspecified

115.9

307.7

412

N03AX16

ATC

[U] pregabalin

6.3

307.7

4891

12820

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

18.8

307.7

279

152

WX725

NOMESCO Finland

Noninvasive ventilation

5.2

307.7

1277

2748

L03

ICPC

Low back symptom/complaint

4.0

307.7

5113

20227

G55.1*M51.9

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders (M50-M51+)

270.3

307.7

1133

M54.5

ICD-10 Finland

Low back pain

3.7

307.7

5898

26912

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

8.3

307.7

1420

1935

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

12.6

307.7

969

839

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

7.1

307.7

1421

2272

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

11.5

307.7

487

441

G54.8

ICD-10 Finland

Other nerve root and plexus disorders

191.2

307.7

261

Z01.8

ICD-10 Finland

Other specified special examinations

2.5

307.7

3014

14745

G55.1

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders

96.5

307.7

988

113

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

7.0

307.7

639

960

M03BC01

ATC

orphenadrine (citrate); systemic

2.6

307.7

3202

15159

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

42.9

307.7

596

147

G56.0

ICD-10 Finland

Carpal tunnel syndrome

15.1

307.7

2011

1625

TPH04

NOMESCO Finland

Cathetrisation of vein

2.6

307.7

3043

14154

AB5CT

NOMESCO Finland

Blockage of nerv root with CT guidance

25.1

307.7

397

164

M79.6

ICD-10 Finland

Pain in limb

2.3

307.7

5471

33344

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

48.2

307.7

522

114

M43.1

ICD-10 Finland

Spondylolisthesis

5.1

307.7

808

1680

N06AA09

ATC

amitriptyline; systemic

3.6

307.7

1370

4248

ABC26

NOMESCO Finland

Open discectomy of lumbar spine

14.3

307.7

869

658

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

9.8

307.7

556

596

G56.2

ICD-10 Finland

Lesion of ulnar nerve

15.6

307.7

465

311

N02BF02

ATC

pregabalin; oral

5.2

307.7

1501

3275

ACC51

NOMESCO Finland

Release of median nerve

126.1

307.7

1004

N06AX21

ATC

duloxetine; oral

4.5

307.7

2331

6300

M50.3

ICD-10 Finland

Other cervical disc degeneration

7.2

307.7

563

815

M54.9

ICD-10 Finland

Dorsalgia, unspecified

3.2

307.7

2002

7280

M47.9

ICD-10 Finland

Spondylosis, unspecified

12.9

307.7

1151

996

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

318.4

307.7

5518

367

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

6.2

307.7

738

1271

M54.3

ICD-10 Finland

Sciatica

5.0

307.7

1288

2837

WX704

NOMESCO Finland

Intubation

5.2

307.7

1966

4496

ABC66

NOMESCO Finland

Decompression of lumbal spinal channel

31.5

307.7

273

WX720

NOMESCO Finland

Own respiration

4.8

307.7

1039

2345

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

10.9

307.7

962

966

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

10.4

307.7

3654

5142

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

12.9

307.7

5358

7891

M54.1

ICD-10 Finland

Radiculopathy

6.9

307.7

1041

1648

N02AJ06

ATC

codeine and paracetamol; systemic

3.1

307.7

6181

33289

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

8.6

307.7

1148

1482

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

10.8

307.7

1635

1771

M54.4

ICD-10 Finland

Lumbago with sciatica

7.4

307.7

4857

11039

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

6.9

307.7

2252

4021

XA402

NOMESCO Finland

ENMG

9.5

307.7

558

615

N02BF01

ATC

gabapentin; oral

7.4

307.7

2920

5216

G55.2

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

141.4

307.7

625

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.6

307.7

5742

32981

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

6.4

307.7

2415

4658

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

5.0

307.7

812

1718

L86

ICPC

Back syndrome with radiating pain

7.1

307.7

1731

2844

M54.2

ICD-10 Finland

Cervicalgia

3.3

304.7

1283

4251

M96.1

ICD-10 Finland

Postlaminectomy syndrome, not elsewhere classified

17.3

302.3

249

147

M53.1

ICD-10 Finland

Cervicobrachial syndrome

2.8

296.6

1733

6907

XX2CT

NOMESCO Finland

Other injection with CT guidance

42.9

296.4

177

SPAT1153

SPAT

Removal of sutures

2.2

293.4

3571

19875

N02BE01

ATC

paracetamol; systemic, rectal

4.1

285.9

9807

82797

R4110, ,

SPAT

2.7

283.9

1867

7892

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

5.5

279.5

557

1055

N06AX16

ATC

venlafaxine; oral

2.6

271.3

1948

8578

NAG66

NOMESCO Finland

Posterior interbody fusion of lumbar spine, 2 vertebrae

12.6

269.0

265

216

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

9.0

268.9

336

385

M47.82

ICD-10 Finland

Other spondylosis, cervical region

4.4

262.0

681

1613

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

7.7

252.9

360

483

A02BC02

ATC

pantoprazole; systemic

2.1

248.3

7546

57579

N02AA05

ATC

oxycodone; systemic

2.4

240.6

2074

9879

WX702

NOMESCO Finland

Supraglottic ventilation device

3.4

240.5

939

2953

SPAT1263

SPAT

Sampling

2.0

239.8

4562

29419

A02BC03

ATC

lansoprazole; oral

2.1

235.2

3189

18203

A01

ICPC

Pain general/multiple sites

2.8

232.0

1328

5195

A02BC05

ATC

esomeprazole; systemic

1.9

228.8

4593

30025

S18

ICPC

Laceration/cut

1.9

225.6

5147

35053

M19.0

ICD-10 Finland

Primary arthrosis of other joints

2.7

223.2

1327

5289

R52.2

ICD-10 Finland

Other chronic pain

4.3

219.5

593

1444

M70.6

ICD-10 Finland

Trochanteric bursitis

2.5

218.7

1648

7363

L01

ICPC

Neck symptom/complaint

2.3

215.2

2058

10198

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

3.1

214.7

960

3271

M25.5

ICD-10 Finland

Pain in joint

1.9

214.2

3864

24226

M01AH01

ATC

celecoxib; oral

2.2

211.6

2082

10432

G56.4

ICD-10 Finland

Causalgia

80.9

210.5

112

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

5.2

206.7

438

874

M01AE03

ATC

ketoprofen; systemic, rectal

1.9

205.9

3976

25413

ZXM20

NOMESCO Finland

Intraoperative use of computerised tomography

10.1

205.0

233

235

R51.80

ICD-10 Finland

Headache

2.3

202.6

1904

9344

H02AB06

ATC

prednisolone; systemic

1.9

199.7

5112

35634

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.0

199.2

945

3327

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

7.6

194.6

278

374

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.9

189.7

4059

26632

G51.0

ICD-10 Finland

Bell palsy

16.5

187.9

158

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

14.9

187.8

167

114

N06AX11

ATC

mirtazapine; oral

1.9

185.3

3791

24480

R52.1

ICD-10 Finland

Chronic intractable pain

9.8

181.8

211

219

G57.3

ICD-10 Finland

Lesion of lateral popliteal nerve

11.1

181.4

193

177

L13

ICPC

Hip symptom/complaint

2.1

179.3

2201

11933

SPAT1301

SPAT

No procedures

1.9

176.2

3193

19772

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

5.1

176.2

378

762

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

4.9

175.2

393

823

M01AE02

ATC

naproxen; oral, rectal

1.8

172.1

6013

45206

Z50.1

ICD-10 Finland

Other physical therapy

3.2

171.5

707

2287

M01AC06

ATC

meloxicam; systemic, rectal

1.8

170.5

3859

25541

G54.4

ICD-10 Finland

Lumbosacral root disorders, not elsewhere classified

71.4

169.8

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

164.5

3051

18953

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

162.8

4914

35217

AA1AD

NOMESCO Finland

CT of head and brain

1.9

161.3

2962

18323

G83.4

ICD-10 Finland

Cauda equina syndrome

15.9

160.0

137

L17

ICPC

Foot/toe symptom/complaint

1.8

157.6

3306

21273

WX110

NOMESCO Finland

Infiltration anesthesia

1.8

156.4

7672

62796

R03AC02

ATC

salbutamol; inhalant

1.7

156.0

5794

43788

7227C

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]

4.2

155.6

424

1036

G99.2*M47.9

ICD-10 Finland

Myelopathy in spondylosis

19.4

155.5

121

M54

ICD-10 Finland

Dorsalgia

2.2

154.2

1554

7772

M01AH02

ATC

rofecoxib; oral

2.3

153.7

1341

6325

2402

FHL

External neurolysis of the nerve and possible alteration of the pathway (nerve pressure)

16.0

153.2

131

M79.1

ICD-10 Finland

Myalgia

2.1

150.1

1738

9159

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.9

149.8

2238

12902

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.2

147.3

1439

7101

G44.2

ICD-10 Finland

Tension-type headache

2.1

146.1

1563

7988

R20.2

ICD-10 Finland

Paraesthesia of skin

2.6

145.7

912

3696

M43.0

ICD-10 Finland

Spondylolysis

5.0

140.5

307

628

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

139.8

4398

31447

M79.7

ICD-10 Finland

Fibromyalgia

3.6

139.5

480

1382

M03BC51

ATC

orphenadrine, combinations; systemic

1.8

138.9

2971

19087

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

3.5

138.9

494

1454

L12

ICPC

Hand/finger symptom/complaint

2.0

138.0

1873

10419

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

5.8

137.3

256

454

N02AJ13

ATC

tramadol and paracetamol; systemic

4.3

136.5

361

862

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

4.9

135.3

302

629

A02BC01

ATC

omeprazole; systemic

1.8

133.4

2718

17180

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.0

133.0

1599

8513

R06.0

ICD-10 Finland

Dyspnoea

1.8

132.9

2727

17270

M01AE01

ATC

ibuprofen; systemic, rectal

2.4

131.2

9604

86369

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

2.7

129.2

764

3004

N06AA10

ATC

nortriptyline; systemic

4.5

128.4

316

713

L08

ICPC

Shoulder symptom/complaint

1.8

128.1

2516

15701

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.8

126.1

2541

15968

N03AE01

ATC

clonazepam; systemic

2.8

125.5

688

2602

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.6

124.4

422

1203

R52.9

ICD-10 Finland

Pain, unspecified

2.2

124.3

1204

5897

SPAT1310

SPAT

Counselling related to known health issue

1.7

123.9

3101

20692

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

10.0

123.5

141

143

M50.9

ICD-10 Finland

Cervical disc disorder, unspecified

7.5

123.4

177

239

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.4

122.9

961

4305

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

122.4

2899

19044

SPAT1097

SPAT

Recording of ECG

2.0

122.1

1470

7811

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

2.5

121.4

809

3369

TPH07

NOMESCO Finland

Cathetrisation of artery

2.1

121.3

1249

6262

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.6

120.6

4012

28783

G99.2*M51.0

ICD-10 Finland

Lumbar and other intervertebral disc disorders with myelopathy

14.2

118.4

108

L28

ICPC

Limited function/disability (L)

1.9

118.4

1802

10363

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

2.7

118.1

688

2683

M01AX17

ATC

nimesulide; oral

1.8

118.0

2322

14448

ACC19

NOMESCO Finland

Transcision of peripheral nerve: other or unspecified

31.0

118.0

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

3.1

117.9

514

1713

N05CF01

ATC

zopiclone; oral

1.7

117.1

3155

21407

J01MA02

ATC

ciprofloxacin; systemic

1.6

116.1

3871

27711

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.6

115.9

4886

37016

A06AC01

ATC

ispaghula (psylla seeds); oral

1.7

115.6

2655

17247

R02

ICPC

Shortness of breath/dyspnoea

2.0

115.4

1427

7643

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.6

114.8

5871

46517

SPAT1260

SPAT

Consultation of another employee

1.9

114.7

1754

10091

N03AX09

ATC

lamotrigine; oral

2.8

114.7

603

2229

J01DB01

ATC

cefalexin; oral

1.8

113.5

8594

75138

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

112.1

1901

11292

SAA01

NOMESCO Finland

Simple examination of mouth

1.7

111.2

7578

64125

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.0

111.1

1406

7586

A02BA02

ATC

ranitidine; systemic

1.8

108.9

1813

10697

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

108.2

2040

12496

NF1AA

NOMESCO Finland

Hip X-ray examination

2.2

107.8

943

4420

J01AA02

ATC

doxycycline; systemic

1.7

107.4

7961

68451

R42

ICD-10 Finland

Dizziness and giddiness

1.7

107.4

2258

14268

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.1

107.1

1079

5351

M02AA07

ATC

piroxicam; topical

1.6

107.0

3396

23901

L84

ICPC

Back syndrome without radiat pain

2.7

106.7

609

2348

J01FF01

ATC

clindamycin; systemic

1.7

106.6

2751

18369

G50.1

ICD-10 Finland

Atypical facial pain

6.8

106.4

167

249

SAA03

NOMESCO Finland

Extended examination of mouth

1.6

106.1

4015

29459

9211

FHL

Exploration or removal of diskusprolapse

4.2

105.6

283

682

M16.1

ICD-10 Finland

Other primary coxarthrosis

2.1

105.4

1175

6052

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.1

104.8

1045

5160

M77.1

ICD-10 Finland

Lateral epicondylitis

2.2

104.6

965

4620

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.7

104.1

612

2394

NAG65

NOMESCO Finland

Anterior and posterior fusion of lumbar spine

10.9

103.4

111

103

G50.0

ICD-10 Finland

Trigeminal neuralgia

8.0

103.3

140

177

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.0

102.8

1243

6588

NF1DA

NOMESCO Finland

X-ray of hips

4.1

102.1

285

708

M76.0

ICD-10 Finland

Gluteal tendinitis

3.8

102.0

324

883

WX400

NOMESCO Finland

Inhalation anesthesy

2.8

101.8

520

1891

Z01.9

ICD-10 Finland

Special examination, unspecified

2.5

101.6

704

2979

ZSA00

NOMESCO Finland

Procedure related to previous procedure classified in chapter A

12.6

101.6

M01AH03

ATC

valdecoxib; oral

2.5

100.8

702

2977

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

9.1

100.4

123

137

OAB36

NOMESCO Finland

Guidance and counselling related to exercise

7.8

99.2

137

177

SAA02

NOMESCO Finland

Basic examination of mouth

1.6

99.0

6942

58173

UJF32

NOMESCO Finland

Coloscopy

1.7

98.8

2537

16863

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.5

98.7

676

2845

L15

ICPC

Knee symptom/complaint

1.7

98.6

2556

17031

ABC60

NOMESCO Finland

Decompression of cervical spinal cord

8.5

98.5

127

151

M54.8

ICD-10 Finland

Other dorsalgia

2.7

97.8

567

2202

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

2.4

97.7

748

3309

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

97.5

1879

11543

R01AD09

ATC

mometasone; nasal

1.5

97.1

4667

35918

G57.6

ICD-10 Finland

Lesion of plantar nerve

5.4

97.1

191

356

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.9

96.2

1398

7874

P01AB01

ATC

metronidazole; oral, rectal

1.6

96.2

4021

29986

NA3CM

NOMESCO Finland

Lumbar spine extensive MRI examination with 3 Tesla magnet

13.3

95.4

L02

ICPC

Back symptom/complaint

2.0

95.3

1140

6010

TAB20

NOMESCO Finland

Epidural puncture

6.7

95.0

150

225

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

94.9

1116

5848

NA1BG, ,

SPAT

3.7

94.4

304

836

G99.2*M47.1

ICD-10 Finland

Spondylogenic compression of spinal cord

8.1

94.1

126

157

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

94.0

1891

11746

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

5.3

92.7

186

353

J01FA10

ATC

azithromycin; systemic

1.5

92.5

5822

47280

M03BX01

ATC

baclofen; systemic

4.1

92.2

258

642

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

7.5

92.1

132

178

A06AD11

ATC

lactulose; oral

1.9

91.8

1272

7048

WX290

NOMESCO Finland

Other blockage of nerve

1.5

91.3

4953

38935

AEA24

NOMESCO Finland

Removal of spinal stimulation elecrode

12.5

90.6

G47.3

ICD-10 Finland

Sleep apnoea

1.6

90.5

2493

16809

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.3

90.1

738

3358

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

90.1

2740

18925

UKC02

NOMESCO Finland

Cystoscopy

1.8

89.9

1459

8498

R1100, ,

SPAT

4.7

89.7

211

459

G54.2

ICD-10 Finland

Cervical root disorders, not elsewhere classified

41.7

89.6

G99.2

ICD-10 Finland

Myelopathy in diseases classified elsewhere

14.3

89.4

M65.3

ICD-10 Finland

Trigger finger

2.8

89.3

464

1702

SFA10

NOMESCO Finland

One-surface restoration

1.5

89.3

5670

45978

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

2.3

88.5

713

3221

G56.3

ICD-10 Finland

Lesion of radial nerve

13.0

87.8

M54.6

ICD-10 Finland

Pain in thoracic spine

2.2

87.7

830

4004

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.9

87.7

415

1447

J01DA09

ATC

[U] cefadroxil

1.6

87.2

2629

18093

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

2.9

87.2

419

1473

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.3

86.9

715

3258

R96

ICPC

Asthma

2.0

86.7

1039

5473

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

3.1

86.7

374

1237

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

86.6

5283

42369

UDC00

NOMESCO Finland

Ear microscopy

2.2

86.4

774

3653

TQW40, ,

SPAT

2.0

86.1

1091

5859

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.0

86.0

969

4993

Z01.2

ICD-10 Finland

Dental examination

1.5

85.3

4789

37716

R09

ICPC

Sinus symptom/complaint

2.1

84.8

894

4494

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

84.4

2530

17368

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.8

83.9

1356

7876

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.1

83.6

884

4448

NAU20

NOMESCO Finland

Removal of internal fixation device from spine or neck

10.9

83.3

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.9

83.2

1080

5843

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.4

83.0

618

2697

M01AX01

ATC

nabumetone; oral

2.8

82.7

440

1633

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.0

82.4

996

5258

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

82.2

2954

21123

ZXC95

NOMESCO Finland

Use of surgical navigator

4.5

82.0

202

456

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

3.6

81.9

271

759

M53.2

ICD-10 Finland

Spinal instabilities

6.1

81.4

142

236

J01DA01

ATC

[U] cefalexin

1.5

81.2

6020

49930

L83

ICPC

Neck syndrome

5.8

81.1

150

264

R01AD58

ATC

fluticasone, combinations; nasal

1.6

81.0

2633

18389

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.0

80.7

913

4706

R05

ICPC

Cough

1.6

80.7

2473

17035

SFA20

NOMESCO Finland

Two-surface restoration

1.5

80.5

6068

50458

X58

ICD-10 Finland

Exposure to other specified factors

1.7

80.4

1557

9528

NAG67

NOMESCO Finland

Posterior interbody fusion of lumbar spine, more than 2 vertebrae

30.7

79.3

N05AH04

ATC

quetiapine; oral

1.7

78.5

1750

11125

M51.2

ICD-10 Finland

Other specified intervertebral disc displacement

7.2

78.1

116

163

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

77.7

2890

20771

N01

ICPC

Headache

1.9

77.5

1085

6013

AEA20

NOMESCO Finland

Removal of impulse generator of stimulation device in the nervous system

19.5

77.2

OAB93, ,

SPAT

2.1

77.2

802

4005

EB1VA, ,

NOMESCO Finland

1.6

77.1

1959

12875

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.5

77.1

505

2078

K02.1

ICD-10 Finland

Caries of dentine

1.5

76.4

6034

50381

M01AX05

ATC

glucosamine; oral

1.7

76.3

1588

9902

OAA65, ,

SPAT

1.6

76.0

2042

13601

NA3CG, ,

SPAT

4.3

75.9

201

480

N02AC04

ATC

dextropropoxyphene; oral

3.1

75.8

330

1097

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

3.1

75.7

328

1087

J01FA09

ATC

clarithromycin; systemic

1.5

75.3

3087

22623

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.9

75.2

1017

5571

SPAT1262

SPAT

Handing over of treatment supplies

1.7

74.7

1571

9819

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.9

74.6

971

5250

G551, M501,

ICD-10 Finland

+∞

74.0

WX320

NOMESCO Finland

Spinalanesthesy

1.6

73.8

2334

16142

L14

ICPC

Leg/thigh symptom/complaint

2.0

73.8

830

4264

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.9

73.4

984

5372

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

4.8

73.2

168

358

M96.0

ICD-10 Finland

Pseudarthrosis after fusion or arthrodesis

8.0

73.1

125

G552, M501,

ICD-10 Finland

+∞

73.0

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

72.9

2862

20753

N05BA04

ATC

oxazepam; oral

1.5

72.0

2483

17500

NAG41

NOMESCO Finland

Anterior fusion of cervical spine with fixation

7.3

70.9

104

144

3540A

ICD-9 Finland

Mononeuritis of upper limb and mononeuritis multiplex, Carpal tunnel syndrome

+∞

70.9

M01AB55

ATC

diclofenac, combinations; oral

2.2

70.7

605

2797

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

4.6

70.6

170

377

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.9

70.5

347

1235

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

70.4

666

3205

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.6

70.0

420

1656

JN3AD

NOMESCO Finland

Abdominal CT examination

1.7

70.0

1332

8087

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.2

69.9

613

2862

K30

ICD-10 Finland

Functional dyspepsia

1.8

69.9

1174

6874

J02AC01

ATC

fluconazole; systemic

1.5

69.8

3788

29262

J01CA04

ATC

amoxicillin; systemic

1.6

69.8

8219

73591

WZA90

NOMESCO Finland

Other medical or dental certificate

1.6

69.4

2257

15680

XQ855, ,

SPAT

4.2

69.2

185

445

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.9

69.2

886

4759

SPAT1254

SPAT

Administration of medicine

1.8

69.0

1250

7480

G99.2*M50.0

ICD-10 Finland

Cervical disc disorder with myelopathy

7.6

69.0

128

R01BA52

ATC

pseudoephedrine, combinations; oral

1.5

68.9

2934

21588

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.9

68.9

909

4932

NBA30

NOMESCO Finland

Exploration of joint of shoulder or upper arm, arthroscopic

3.0

68.7

305

1025

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.8

68.6

1037

5877

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.9

68.5

1021

5763

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.5

68.4

2418

17101

M89.0

ICD-10 Finland

Algoneurodystrophy

6.2

68.3

117

191

P03

ICPC

Feeling depressed

1.9

68.2

994

5570

L29

ICPC

Musculoskeletal sympt/complt other

1.9

68.1

919

5022

N93

ICPC

Carpal tunnel syndrome

6.7

68.1

108

163

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.8

68.1

1111

6447

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.0

67.8

737

3737

R53

ICD-10 Finland

Malaise and fatigue

1.5

67.7

2375

16766

R03BA05

ATC

fluticasone; inhalant

1.6

67.4

1712

11209

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.3

67.2

550

2496

WX200

NOMESCO Finland

Interscalenous plexus blockade

3.3

67.1

259

801

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

7.1

67.1

101

144

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.5

66.8

3084

23036

N04BC05

ATC

pramipexole; oral

2.1

66.8

710

3571

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.6

66.6

1931

13048

A02BC04

ATC

rabeprazole; oral

1.9

66.5

914

5025

XF600, ,

SPAT

2.5

66.4

430

1758

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.3

66.4

510

2253

D07AC01

ATC

betamethasone; topical

1.5

66.0

3526

27080

XF402

NOMESCO Finland

ECG with work load test

1.9

65.8

962

5393

OAA81, ,

SPAT

2.4

65.6

465

1982

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.9

65.5

323

1151

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

4.4

65.3

165

380

D01

ICPC

Abdominal pain/cramps general

1.7

65.2

1205

7245

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.7

65.0

1305

8029

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

2.9

64.6

320

1143

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

3.3

64.4

250

776

N06AX26

ATC

vortioxetine; oral

2.0

64.2

795

4219

SPAT1212

SPAT

Extensive examination of musculoskeletal system

2.0

63.9

719

3689

XG410

NOMESCO Finland

Flow-volume spirometry

2.6

63.6

392

1566

N05CF02

ATC

zolpidem; oral

1.6

63.5

1710

11340

C01DA14

ATC

isosorbide mononitrate; oral

1.8

63.5

1076

6308

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

63.4

5621

47182

OAB50, ,

SPAT

1.9

63.0

830

4496

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.8

63.0

1086

6398

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.7

62.8

1185

7163

G56.9

ICD-10 Finland

Mononeuropathy of upper limb, unspecified

9.0

62.7

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.8

62.7

1102

6527

SPAT1240

SPAT

Therapeutic discussion

1.8

62.1

987

5673

NG1DA

NOMESCO Finland

X-ray of knees

3.5

62.1

218

635

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

62.1

1810

12225

C07AB07

ATC

bisoprolol; oral

1.4

61.8

4277

34319

C10AX09

ATC

ezetimibe; oral

1.6

61.8

1649

10906

R74

ICPC

Upper respiratory infection acute

1.4

61.5

3254

24865

ZXE20

NOMESCO Finland

More than three and less than five hours

1.7

61.4

1199

7314

R1430, ,

SPAT

3.6

61.2

208

593

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.7

61.2

1272

7894

NBG00

NOMESCO Finland

Plastic operation on acromioclavicular joint

3.6

61.1

205

580

ABD99

NOMESCO Finland

Other operation on spinal cord or nerve for pain or impaired function

11.8

60.9

M48.9

ICD-10 Finland

Spondylopathy, unspecified

7.4

60.9

120

K59.09

ICD-10 Finland

Constipation, unspecified

2.1

60.7

641

3213

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

60.6

3572

27824

XKC03

NOMESCO Finland

Water cystometry

2.8

60.5

313

1144

NA3BM

NOMESCO Finland

Lumbar spine MRI examination with 3 Tesla magnet

9.2

60.3

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

2.2

60.2

531

2483

WZA00

NOMESCO Finland

Concise certificate

2.0

60.1

666

3397

G57.1

ICD-10 Finland

Meralgia paraesthetica

4.2

60.0

162

393

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.8

59.8

301

1084

G04BD12

ATC

mirabegron; oral

1.8

59.8

1075

6406

SPAT1058

SPAT

PEF monitoring instruction

2.0

59.7

743

3947

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

3.4

59.6

219

657

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

59.5

2345

16895

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

59.5

1936

13391

N07BC02

ATC

methadone; systemic

8.7

59.3

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

59.2

1757

11900

NBF25

NOMESCO Finland

Operation for humeroscapular osteochondritis, arthroscopic

3.0

59.0

259

865

D02

ICPC

Abdominal pain epigastric

2.0

58.9

643

3262

C08CA01

ATC

amlodipine; oral

1.4

58.7

3418

26526

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

58.5

2104

14863

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

58.4

1085

6524

R75

ICPC

Sinusitis acute/chronic

2.2

58.2

511

2385

C10AA07

ATC

rosuvastatin; oral

1.4

58.1

3296

25448

ABC50

NOMESCO Finland

Decopression of cervical spinal canal and nerve roots

10.9

58.1

L16

ICPC

Ankle symptom/complaint

1.7

57.7

1150

7048

Z46.9

ICD-10 Finland

Fitting and adjustment of unspecified device

4.3

57.6

151

358

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.8

57.6

290

1045

N06AB04

ATC

citalopram; systemic

1.5

57.4

1911

13270

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.8

57.4

294

1069

SFA30

NOMESCO Finland

Three-surface restoration

1.4

57.4

4265

34504

N05BA01

ATC

diazepam; systemic, rectal

1.7

57.2

1174

7251

M02AA10

ATC

ketoprofen; topical

1.6

57.2

1456

9505

G04CA02

ATC

tamsulosin; oral

1.5

57.1

1890

13105

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.0

56.9

665

3455

KMAK, ,

NOMESCO Finland

1.4

56.9

5030

41870

AAK10

NOMESCO Finland

Repair of dura

17.8

56.7

R03DC03

ATC

montelukast; oral

1.6

56.2

1576

10525

J01EA01

ATC

trimethoprim; systemic

1.5

56.1

2215

15936

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.1

56.1

564

2775

WVA20, ,

SPAT

2.4

56.0

389

1643

HAMTE, ,

NOMESCO Finland

4.8

55.8

127

269

E66.01

ICD-10 Finland

Obesity due to excess calories

1.8

55.8

943

5514

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.7

55.4

1035

6228

AWE00

NOMESCO Finland

Reoperation for deep heamorrhage in surgery of the nervous system

13.4

55.3

J01FA06

ATC

roxithromycin; oral

1.4

55.0

3646

28864

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

2.8

54.9

291

1077

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

2.1

54.8

541

2643

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.4

54.7

386

1641

N06AB10

ATC

escitalopram; oral

1.5

54.2

1963

13861

R07.3

ICD-10 Finland

Other chest pain

1.7

54.2

990

5919

N03AF01

ATC

carbamazepine; oral, rectal

2.3

54.0

410

1801

SAA04

NOMESCO Finland

Special examination of mouth

2.2

53.5

487

2306

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.8

53.4

266

953

M51

ICD-10 Finland

Other intervertebral disc disorders

5.2

53.2

109

211

R01AD12

ATC

fluticasone furoate; nasal

1.4

52.9

3065

23664

G56.1

ICD-10 Finland

Other lesions of median nerve

19.6

52.8

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

52.6

1130

7055

K10.3

ICD-10 Finland

Alveolitis of jaws

2.1

52.6

499

2401

C07AA05

ATC

propranolol; systemic

1.5

52.4

1887

13294

D06

ICPC

Abdominal pain localized other

1.8

52.3

872

5075

XQ858, ,

SPAT

5.4

52.3

102

189

C10AA05

ATC

atorvastatin; oral

1.4

52.2

3812

30600

R06AE07

ATC

cetirizine; oral

1.4

52.0

4158

33870

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.7

51.9

1143

7182

S06.0

ICD-10 Finland

Concussion

1.7

51.9

982

5926

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

2.0

51.8

558

2814

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

51.6

4172

34034

R13

ICD-10 Finland

Dysphagia

1.9

51.4

646

3439

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.1

51.4

487

2342

L11

ICPC

Wrist symptom/complaint

1.8

51.1

799

4561

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.6

51.0

1221

7835

WX002

NOMESCO Finland

Sedation and analgesia

1.5

50.5

1658

11444

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

3.5

50.3

171

488

H01

ICPC

Ear pain/earache

1.7

50.2

1092

6836

C03CA01

ATC

furosemide; systemic

1.5

50.2

2186

15986

SPAT1229

SPAT

Assessment of need for aid

2.0

50.1

600

3142

M01AC01

ATC

piroxicam; systemic, rectal

1.6

49.9

1150

7305

R01AD08

ATC

fluticasone; nasal

1.4

49.8

2713

20675

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.9

49.7

676

3694

SGA01

NOMESCO Finland

Emergency treatment

1.5

49.6

1652

11436

M70.7

ICD-10 Finland

Other bursitis of hip

2.7

49.6

267

997

NJ3NA

NOMESCO Finland

Measurement of difference in extremity lengty with X-ray

3.5

49.4

170

489

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.2

49.2

425

1969

SPAT1044

SPAT

Tympanometry

3.0

49.2

218

732

NBG10

NOMESCO Finland

Acromioplastia

2.9

49.2

238

840

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

3.2

49.1

201

645

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.0

49.1

536

2717

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.0

49.0

586

3067

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.2

48.9

434

2033

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.9

48.9

694

3843

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

48.9

1224

7936

G57.8

ICD-10 Finland

Other mononeuropathies of lower limb

10.0

48.6

EBA00

NOMESCO Finland

Extraction of tooth

1.4

48.5

3406

27080

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

2.9

48.4

229

798

XQ845

NOMESCO Finland

Dermatoscopy

3.0

48.2

216

730

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.8

48.2

705

3940

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.7

48.2

1074

6763

-1, ,

ICPC

2.3

48.1

364

1596

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

3.3

47.8

185

574

P01

ICPC

Feeling anxious/nervous/tense

1.6

47.7

1122

7161

NAW00

NOMESCO Finland

Repair of wound dehiscence in surgery of spine or neck

14.4

47.6

M51.0

ICD-10 Finland

Lumbar and other intervertebral disc disorders with myelopathy

11.2

47.5

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

47.4

1195

7756

ZXA05

NOMESCO Finland

Left side

1.5

47.4

1947

14058

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

47.3

3809

30917

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

2.3

47.3

350

1520

P76

ICPC

Depressive disorder

1.9

47.2

644

3521

H04.10

ICD-10 Finland

Dry eye syndrome

1.6

47.0

1129

7243

G43.9

ICD-10 Finland

Migraine, unspecified

1.9

46.9

577

3048

A11

ICPC

Chest pain NOS

1.8

46.8

789

4602

N07BA03

ATC

varenicline; oral

2.0

46.7

524

2681

SPAT1081

SPAT

Cardiorespiratory global assessment

2.1

46.4

459

2243

M18.1

ICD-10 Finland

Other primary arthrosis of first carpometacarpal joint

3.1

46.4

197

646

D11

ICPC

Diarrhoea

1.6

46.3

1125

7235

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.5

46.3

1988

14468

L09

ICPC

Arm symptom/complaint

2.1

46.3

470

2319

ZZH40

NOMESCO Finland

Substitute of bone

4.3

46.2

121

287

NA3CF

NOMESCO Finland

Lumbar spine extensive MRI examination with median intensity magnet

8.4

46.2

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.9

46.1

613

3323

K07.60

ICD-10 Finland

Snapping jaw

2.0

46.1

490

2459

R51.81

ICD-10 Finland

Facial pain NOS

2.8

46.0

235

854

WX120

NOMESCO Finland

Intravenous local anesthesy of arm

4.6

45.8

108

236

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.9

45.7

592

3182

L90

ICPC

Osteoarthrosis of knee

1.9

45.4

612

3333

SFA00

NOMESCO Finland

Small restoration

1.6

45.3

1352

9121

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.6

45.2

1239

8197

SPAT1202

SPAT

Intra-articular injection

2.6

45.2

270

1062

WX308

NOMESCO Finland

Sacral anesthesy

8.2

44.8

L85

ICPC

Acquired deformity of spine

8.2

44.8

WW502

NOMESCO Finland

Autotransfusion

4.9

44.8

201

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.4

44.7

321

1375

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

44.7

2385

18046

B01AC04

ATC

clopidogrel; oral

1.6

44.7

1271

8480

R35

ICD-10 Finland

Polyuria

1.9

44.4

622

3427

TAB00

NOMESCO Finland

Lumbar puncture

2.1

44.3

424

2045

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

3.6

44.3

145

404

R03BA08

ATC

ciclesonide; inhalant

1.7

44.1

815

4878

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.5

44.1

1390

9488

M01AB08

ATC

etodolac; oral

1.8

44.0

650

3642

WZC00, ,

SPAT

1.5

44.0

1383

9434

M41.9

ICD-10 Finland

Scoliosis, unspecified

3.7

44.0

142

392

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.9

43.9

617

3404

TAC99

NOMESCO Finland

Other blockade for chronic pain

5.5

43.9

153

M41.8

ICD-10 Finland

Other forms of scoliosis

5.6

43.7

150

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.8

43.7

683

3893

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

4.5

43.7

107

241

M50.8

ICD-10 Finland

Other cervical disc disorders

5.9

43.7

133

A01AB09

ATC

miconazole; local oral

1.8

43.4

711

4109

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.6

43.4

1166

7673

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

43.4

1641

11631

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

43.3

4892

41597

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.1

43.3

399

1897

M67.0

ICD-10 Finland

Short Achilles tendon (acquired)

4.5

43.2

104

231

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.7

43.2

782

4652

M50

ICD-10 Finland

Cervical disc disorders

4.3

43.1

110

256

R06AX27

ATC

desloratadine; oral

1.4

43.1

2716

21124

RF210, ,

NOMESCO Finland

2.6

43.1

263

1046

SPAT1216

SPAT

Assessment of functional ability

1.6

42.9

1165

7686

WX204

NOMESCO Finland

Axillary plexus blockaced

2.4

42.9

315

1364

AB6CG

NOMESCO Finland

Extensive MRI of brachial plexus

17.6

42.8

G58.8

ICD-10 Finland

Other specified mononeuropathies

17.6

42.8

M13.9

ICD-10 Finland

Arthritis, unspecified

1.8

42.8

681

3902

35399

ICD-8 Finland

Sciatica

+∞

42.7

ZXD05

NOMESCO Finland

Urgent procedure

1.4

42.7

2626

20336

Z71.9

ICD-10 Finland

Counselling, unspecified

1.7

42.5

778

4642

WYA20, ,

SPAT

4.6

42.3

100

219

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3032080) INR in Blood by Coagulation assay

6052

40227

2.20

307.65

10.0

13.5

1.13

1.22

inr

40.65

5079

33290

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

6477

42161

2.42

307.65

3.1

2.7

—

estimate

—

(3047181) Lactate [Moles/volume] in Blood

888

2507

3.78

268.89

5.7

6.2

1.23

1.30

mmol/l

1.60

787

2213

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

8458

67248

2.37

255.12

5.8

4.2

10.82

11.36

mm/h

3.52

8051

63315

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

4514

28643

2.02

252.21

3.0

2.6

64.24

64.99

u/l

0.05

4232

26652

(3013826) Glucose [Moles/volume] in Serum or Plasma

7075

52581

2.08

251.98

5.5

5.0

6.55

6.63

mmol/l

3.16

6704

49806

(3039000) Anion gap in Blood by calculation

667

1731

4.05

226.72

6.3

7.5

10.99

11.34

mmol/l

1.84

605

1560

(3018572) Chloride [Moles/volume] in Blood

667

1732

4.05

226.53

6.3

7.5

105.03

105.09

mmol/l

0.11

605

1562

(3037467) Urinalysis macro (dipstick) panel - Urine

7796

61372

2.07

219.20

5.7

4.3

1.56

2.16

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

4221

27185

1.93

216.41

2.5

2.2

169.85

211.49

u/l

3.34

4010

25759

(3007930) Methemoglobin/Hemoglobin.total in Blood

982

3466

3.02

206.28

5.9

5.5

0.94

0.89

3.52

920

3282

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1013

3793

2.85

190.62

5.8

5.2

1.78

1.65

3.46

952

3595

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2877

16984

1.96

185.09

1.4

1.3

23.85

31.27

iu/ml

2.98

960

5209

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

5962

44373

1.80

180.20

7.5

7.3

1.22

1.21

mmol/l

2.46

5138

38407

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2665

15616

1.95

173.43

1.4

1.3

7.76

11.69

u/ml

2.60

829

6349

(3024561) Albumin [Mass/volume] in Serum or Plasma

5483

40261

1.76

169.06

5.2

36.39

35.97

g/l

7.12

5130

37884

(3019150) Specific gravity of Urine by Refractometry

3244

20683

1.83

159.91

4.2

3.8

1.44

1.09

kg/l

0.38

2408

13567

(3031040) Bacteria [#/volume] in Urine by Automated count

7204

57932

1.79

155.04

5.6

4.3

3575.63

1767.29

e6/l

0.53

745

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

8317

70000

1.93

153.14

8.8

8.3

75.50

78.21

u/l

8.31

8040

66684

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1344

6359

2.28

152.81

3.3

2.9

96.66

173.77

ng/l

23.72

1249

5797

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

6197

47858

1.73

152.77

6.0

6.9

10.12

11.47

umol/l

28.51

5928

45735

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4522

32054

1.73

152.52

3.6

3.4

30.91

34.40

u/l

3.63

4298

30320

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1158

5172

2.39

150.35

6.5

7.2

24.67

24.51

mmol/l

0.75

1090

4955

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

4610

33163

1.70

144.87

4.4

3.4

37.97

46.71

ng/l

0.53

3099

21809

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

5303

39651

1.69

143.62

6.2

6.7

1.21

mmol/l

1.41

4903

36871

(3044640) Blood type and Crossmatch panel - Blood

4143

29276

1.69

136.84

2.6

2.4

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2723

17123

1.80

136.52

4.5

3.7

257.41

497.85

ng/l

2.47

2016

12964

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

5186

38916

1.66

135.44

2.3

2.0

99.95

96.30

pmol/l

5.85

2809

20878

(3019550) Sodium [Moles/volume] in Serum or Plasma

10009

91702

3.30

134.39

21.8

17.0

139.68

139.73

mmol/l

1.46

9920

90012

(3023103) Potassium [Moles/volume] in Serum or Plasma

10021

91961

3.33

132.42

22.0

17.2

3.98

3.96

mmol/l

10.40

9918

90114

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

9875

90108

2.82

128.09

19.6

14.8

20.51

24.08

mg/l

26.21

8621

73441

(3035350) Ketones [Presence] in Urine by Test strip

6146

48628

1.64

126.36

4.3

3.7

2.47

4.33

estimate

0.48

1088

10013

(3009261) Glucose [Presence] in Urine by Test strip

6175

48952

1.64

125.64

4.4

3.7

1.05

0.26

estimate

0.38

1026

9494

(3019069) Monocytes/Leukocytes in Blood

5589

43328

1.63

123.55

6.8

6.7

8.80

8.82

0.21

5295

40782

(3022096) Basophils/Leukocytes in Blood

5574

43234

1.62

122.53

6.8

6.7

0.70

0.69

0.65

5271

40621

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1104

5256

2.23

122.17

7.8

10.9

16.66

16.09

9.55

1041

5090

(3006504) Eosinophils/Leukocytes in Blood

5570

43238

1.62

121.67

6.7

6.6

2.94

2.84

5274

40677

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

8243

70816

1.78

120.69

4.9

4.3

14.62

14.68

pmol/l

1.46

7663

65697

(3013512) EKG study

4145

30005

1.63

119.98

4.3

3.4

0.86

0.72

—

(3014051) Protein [Presence] in Urine by Test strip

3782

26798

1.65

118.99

3.3

2.8

0.08

0.05

0.22

494

(3026008) Bacteria identified in Urine by Culture

3593

25132

1.66

118.95

3.6

3.0

—

(3002030) Lymphocytes/Leukocytes in Blood

5677

44462

1.61

117.96

6.7

6.6

29.08

28.00

12.69

5434

42249

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

9357

83932

2.12

117.37

6.2

5.2

1.79

1.88

mu/l

13.59

8821

78354

(3018010) Neutrophils/Leukocytes in Blood

5581

43617

1.60

116.30

6.5

56.15

57.13

9.21

5384

41758

(3037522) Nuclear Ab [Titer] in Serum

2138

13081

1.80

114.62

1.5

1.4

413.71

508.33

titre

2.15

455

2776

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

7696

65204

1.69

114.39

4.1

3.3

49.76

47.19

u/l

1.79

7336

61778

(3021601) Nitrite [Presence] in Urine by Test strip

5990

48108

1.58

107.02

4.3

3.7

0.00

estimate

0.06

1063

9864

(3013115) Eosinophils [#/volume] in Blood

6035

48648

1.57

105.30

6.5

6.7

0.20

0.19

e9/l

2.53

5514

42493

(3041096) Erythrocytes [Presence] in Urine by Automated

3681

26617

1.59

102.53

3.6

3.1

0.34

0.05

estimate

0.53

895

7843

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

4769

36607

1.56

102.20

4.2

3.6

2.37

0.23

estimate

1.28

911

8110

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2213

14089

1.72

101.70

2.1

1.9

—

(3019198) Lymphocytes [#/volume] in Blood

5948

48085

1.55

100.03

6.4

6.5

1.97

1.91

e9/l

3.28

5475

42308

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3199

22475

1.61

99.98

2.4

2.3

2.49

2.75

mg/l

10.68

2809

19500

(3006315) Basophils [#/volume] in Blood

5847

47160

1.55

98.79

6.4

6.5

0.04

e9/l

2.96

5298

40474

(3001604) Monocytes [#/volume] in Blood

5832

47044

1.54

98.24

6.3

6.5

0.59

0.58

e9/l

3.53

5292

40373

(3015736) pH of Urine

4970

38738

1.54

97.81

3.8

3.3

6.17

6.19

0.96

3077

21807

(3017732) Neutrophils [#/volume] in Blood

1907

11760

1.76

97.67

3.1

3.3

4.23

4.41

e9/l

0.92

1650

10314

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1742

10488

1.79

96.78

2.0

1.8

—

(3021960) Folate [Moles/volume] in Serum or Plasma

3388

24408

1.57

93.83

1.8

1.7

20.93

20.16

nmol/l

2.17

2903

20880

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2903

20363

1.59

89.25

1.8

0.94

1.18

mg/l

4.30

2258

15802

(3019309) Folate [Moles/volume] in Red Blood Cells

2067

13355

1.68

88.32

1.8

1.7

1109.29

1165.14

nmol/l

2.22

1621

10189

(3009508) Creatinine [Moles/volume] in Urine

4105

31177

1.52

87.96

3.6

3.4

7.85

7.83

mmol/l

0.13

3521

26570

(3020682) Albumin/Creatinine [Ratio] in Urine

3908

29387

1.53

87.65

4.2

4.1

6.10

8.06

mg/mmol

2.45

2392

18206

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1456

8574

1.81

86.25

7.1

9.5

124.44

121.93

g/l

4.90

1390

8390

(3012516) Albumin [Mass/volume] in Urine

3843

28914

1.52

85.33

3.5

3.4

38.22

45.64

mg/l

1.44

2329

18259

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

9483

87320

1.95

82.53

5.8

4.9

5.94

5.88

mmol/l

5.06

8907

81273

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1608

9881

1.74

81.96

2.1

1.8

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2570

17832

1.59

81.42

1.8

1.7

79366979.74

30647953.19

pmol/l

2.09

2147

15042

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1136

6305

1.90

80.95

2.5

2.4

16.69

21.86

au/ml

2.00

117

817

(3020564) Creatinine [Moles/volume] in Serum or Plasma

10181

96632

3.31

80.92

24.5

18.9

75.40

76.41

umol/l

3.16

10133

95616

(3001122) Ferritin [Mass/volume] in Serum or Plasma

5391

43841

1.48

79.66

3.4

3.1

113.21

128.44

ug/l

5.92

5058

41284

(3008898) HLA-B27 [Presence]

691

3230

2.22

78.80

1.1

—

(4024509) Urine culture

783

3862

2.11

77.87

1.9

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2932

21135

1.54

77.78

1.4

1.3

1.92

1.76

u/ml

0.18

634

5932

(3019977) pH of Arterial blood

1638

10274

1.71

77.08

6.9

8.5

7.42

0.17

1071

5387

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

9339

85913

1.84

76.58

7.3

5.9

39.33

38.70

mmol/mol

9.97

8882

81107

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1212

6988

1.83

76.32

1.5

—

(3023368) Bacteria identified in Blood by Culture

3231

23865

1.51

76.11

4.3

4.4

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1049

5815

1.89

74.74

1.3

53.22

51.61

au/ml

0.07

407

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1622

10271

1.69

73.32

6.7

8.5

5.09

5.10

kpa

0.17

1536

9928

(3027801) Oxygen [Partial pressure] in Arterial blood

1621

10266

1.69

73.23

6.7

8.5

12.44

12.68

kpa

1.10

1537

9920

(3003396) Base excess in Arterial blood by calculation

1604

10177

1.68

71.84

6.6

8.5

1.53

0.86

mmol/l

12.55

1280

8501

(3042936) Bacteria identified in Isolate by Culture

1899

12656

1.61

69.79

2.3

2.0

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

6204

52669

1.44

67.84

8.5

10.2

4.16

4.07

e9/l

1.97

5608

45557

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

4920

40087

1.43

67.22

2.1

1.9

1.46

1.38

mmol/l

6.38

4167

34081

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

5072

41623

1.43

66.19

2.7

2.4

77.17

2221.47

nmol/l

0.50

4636

38234

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1385

8632

1.70

65.87

2.2

2.4

358.71

378.75

nmol/l

3.37

1266

8061

(3016502) Oxygen saturation in Arterial blood

1442

9093

1.68

65.61

6.7

9.0

96.43

95.71

5.60

1362

8804

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

10099

96208

2.60

65.35

14.2

11.7

28.09

27.09

u/l

5.44

9905

93768

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2986

22284

1.48

64.50

2.5

2.4

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1609

10481

1.63

64.37

5.5

4.7

31.63

32.06

0.83

1169

7111

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

524

2415

2.23

61.60

1.1

2.84

6.24

eliau/ml

1.97

351

(3044889) 12 lead EKG panel

7289

64338

1.44

60.32

4.5

3.8

0.27

5309.73

0.97

123

(3048689) Calprotectin [Mass/mass] in Stool

1780

12207

1.55

56.51

2.3

2.5

131.33

131.24

ug/g

0.00

1411

9758

(3007853) Bacteria identified in Skin by Aerobe culture

1551

10326

1.59

56.00

1.8

1.7

—

(36660697) Celiac disease serology panel - Serum

1174

7330

1.68

54.80

1.2

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3182

24680

1.42

53.70

3.1

3.0

840.78

1166.58

ng/l

4.20

2642

21146

(3007461) Platelets [#/volume] in Blood

10262

99165

3.26

53.09

29.4

22.6

254.91

252.63

e9/l

3.25

10200

97305

(3015171) Extractable nuclear Ab [Units/volume] in Serum

663

3534

1.94

52.58

1.3

0.92

1.04

u/ml

0.07

279

(3024731) MCV [Entitic mean volume] in Red Blood Cells

10262

99199

3.23

52.39

29.2

22.5

91.11

91.01

1.67

10228

98299

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

10262

99210

3.23

52.16

29.7

23.0

41.02

41.31

0.29

10226

98262

(3035941) MCH [Entitic mass]

10261

99197

3.21

52.12

29.2

22.5

30.44

30.34

8.46

10227

98296

(3026361) Erythrocytes [#/volume] in Blood

10262

99213

3.22

52.10

29.3

22.5

4.51

4.53

e12/l

5.99

10190

97058

(3010813) Leukocytes [#/volume] in Blood

10262

99226

3.21

51.83

29.4

22.6

6.85

6.64

e9/l

23.39

10187

97056

(3000963) Hemoglobin [Mass/volume] in Blood

10262

99232

3.21

51.71

29.5

22.7

136.48

136.59

g/l

0.37

10233

98348

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

9654

91237

1.79

51.60

5.8

5.0

4.68

4.70

mmol/l

0.97

9144

86274

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

9734

92280

1.83

50.61

6.5

5.6

2.74

2.78

mmol/l

4.60

9203

86909

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

472

2258

2.14

50.45

1.3

28.45

3.54

u/ml

—

(3026493) Urate [Moles/volume] in Serum or Plasma

3136

24505

1.40

49.84

2.8

2.7

335.02

340.03

umol/l

2.14

2776

21914

(3005322) IgE [Units/volume] in Serum or Plasma

996

6105

1.70

49.58

1.5

1.3

184.79

250.88

u/ml

1.13

924

5708

(3019225) pH of Specimen

1230

7964

1.62

49.43

4.2

4.1

7.35

7.36

0.12

888

5712

(3045414) Leukocytes [Presence] in Urine

1298

8521

1.60

49.24

2.2

2.1

0.02

estimate

0.04

182

1857

(40768797) Stomach Pathology biopsy report

1799

12711

1.50

48.92

1.3

1.2

—

(3018418) pH of Serum or Plasma

3380

26838

1.38

48.49

3.8

4.4

7.40

1.81

2596

18914

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

9598

90779

1.72

48.17

5.7

4.9

1.43

1.46

mmol/l

10.38

9064

85381

(40758558) Short blood count panel - Blood

3470

27840

1.37

46.08

5.3

6.6

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

999

6253

1.66

45.76

1.7

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

539

2812

1.97

45.43

1.3

20.85

38.69

u/ml

1.33

163

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

764

4484

1.76

44.29

1.2

1.1

7.74

7.34

u/ml

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

741

4317

1.77

44.06

2.6

2.3

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

440

2165

2.08

43.64

1.3

4.59

2.96

u/ml

0.22

146

(3009343) pH of Capillary blood

871

5360

1.68

42.46

3.6

3.4

7.42

0.21

733

4446

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1516

10622

1.50

42.34

1.6

—

6.65

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

892

5532

1.67

42.21

3.6

3.4

5.17

5.14

kpa

0.52

852

5301

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

453

2281

2.03

42.19

1.3

524.14

529.71

mg/l

0.07

429

2183

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

501

2614

1.96

42.19

1.3

5.27

6.32

u/ml

0.16

379

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

6661

59348

1.34

42.07

3.2

3.0

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

500

2620

1.95

41.57

1.3

2.87

4.46

u/ml

0.53

235

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

502

2644

1.94

41.11

1.3

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1923

14236

1.43

40.15

2.5

2.6

2.42

2.33

g/l

9.83

1764

13236

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

766

4628

1.71

39.92

3.3

3.2

1.79

1.74

mmol/l

0.13

580

3430

(3026389) Candida sp identified in Specimen by Organism specific culture

290

1252

2.35

39.73

1.6

1.3

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1859

13722

1.43

39.36

1.9

2.2

28.62

29.67

10.09

1757

13367

(3022948) Iron [Moles/volume] in Serum or Plasma

2040

15312

1.41

39.31

2.5

2.6

13.68

13.51

umol/l

0.45

1889

14366

(3005719) IgG [Mass/volume] in Serum or Plasma

1085

7188

1.57

39.04

2.8

10.14

10.62

g/l

3.66

990

6665

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

403

2007

2.05

38.68

1.2

3.75

3.74

mmol/l

0.09

373

1911

(3045424) Erythrocytes [Presence] in Urine

725

4360

1.71

38.40

2.2

2.1

0.02

estimate

0.11

121

1449

(3023420) DNA double strand Ab [Units/volume] in Serum

658

3852

1.76

38.37

1.7

1.8

8.57

7.32

iu/ml

0.47

140

899

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

669

3979

1.73

36.85

2.0

39.89

40.10

u/l

0.10

595

3563

(3022621) pH of Urine by Test strip

1058

7127

1.54

35.15

2.6

2.4

6.10

6.07

0.61

668

4634

(3017704) Immunofixation for Urine

132

405

3.29

34.80

1.5

1.6

—

(3000330) Specific gravity of Urine by Test strip

684

4196

1.67

33.54

3.6

3.2

1.02

ratio

1.21

628

3766

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

385

1999

1.96

32.86

1.3

1.4

46.65

28.30

e6/l

0.25

307

1427

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

184

704

2.64

32.68

1.1

42.46

42.12

mg/l

0.03

148

593

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

351

1769

2.02

32.61

1.5

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

404

2145

1.92

32.28

1.7

1.6

9988.19

14606.23

e6/l

1.44

310

1496

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

179

681

2.66

32.16

1.1

283.43

264.57

mg/l

0.30

156

606

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

386

2033

1.93

31.60

1.4

2145.01

3144.72

e6/l

0.17

328

1565

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

502

2874

1.78

31.54

3.4

2.6

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

131

426

3.10

31.41

1.3

72.23

68.22

0.16

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

507

2917

1.78

31.32

3.7

3.3

24.90

24.86

mmol/l

0.11

473

2671

(3007164) IgA [Mass/volume] in Serum or Plasma

2357

18681

1.34

31.32

1.5

2.33

2.43

g/l

1.96

1480

11925

(3006571) Granulocytes/Leukocytes in Synovial fluid

225

966

2.36

31.29

1.7

1.6

54.40

57.64

0.53

138

605

(3020630) Protein [Mass/volume] in Serum or Plasma

1038

7172

1.50

30.38

2.5

2.6

67.10

66.58

g/l

1.62

950

6657

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

8238

76947

1.34

30.38

22.3

18.3

13.54

13.55

0.53

8181

75942

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

221

957

2.34

30.15

2.1

2.0

26.61

24.16

mg/l

0.29

351

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

267

1251

2.16

30.13

1.2

13.78

5.33

u/ml

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

259

1202

2.18

29.94

6.7

6.3

11.74

11.55

mg/l

0.27

240

1126

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

143

504

2.86

29.76

1.8

1.5

5.81

6.07

u/l

0.15

116

436

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

286

1389

2.09

29.41

1.5

1.4

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

165

633

2.63

29.19

1.1

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

288

1407

2.08

29.16

3.3

2.5

13.31

13.16

1.76

288

1383

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

9111

86591

1.41

29.12

4.7

4.2

1.40

1.30

mmol/l

29.16

8540

80737

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

384

2078

1.88

28.96

1.5

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

418

2332

1.83

28.62

1.5

1.4

—

(3000494) Fungus identified in Specimen by Culture

1515

11346

1.39

28.59

1.6

1.5

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

556

3370

1.69

28.48

2.0

1.56

1.96

ug/l

0.37

480

3026

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1714

13141

1.36

27.93

2.5

2.6

23.09

23.31

0.25

1578

12286

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1620

12328

1.37

27.64

2.0

1.8

1.52

1.44

4.29

1433

10892

(3037756) Immunofixation for Serum or Plasma

328

1712

1.95

27.60

1.6

1.7

—

(44790047) Parainfluenza type 1 nucleic acid detection

241

1131

2.16

27.12

1.7

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

241

1131

2.16

27.12

1.7

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

241

1131

2.16

27.12

1.7

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

241

1131

2.16

27.12

1.7

1.5

—

(3004616) Nuclear Ab [Presence] in Serum

240

1125

2.16

27.09

1.4

1.3

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

207

919

2.28

26.69

1.2

84.70

40.97

u/ml

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

191

820

2.35

26.62

1.1

1.0

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

953

6646

1.48

26.49

3.3

4.0

77.70

90.92

ng/l

4.73

833

5783

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

181

766

2.39

26.07

1.2

62.20

68.58

u/ml

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

236

1120

2.13

25.83

1.4

1.5

—

(3022145) Colonoscopy Study observation

1438

10877

1.37

25.29

1.3

1.4

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

377

2124

1.80

25.01

1.2

1.3

62.34

42.38

u/ml

1.03

208

(3045716) Anion gap in Serum or Plasma by calculation

201

909

2.24

24.83

4.6

3.3

12.09

10.67

mmol/l

7.08

201

896

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

230

1098

2.12

24.80

1.4

1.5

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

186

817

2.30

24.63

1.8

1.4

1.30

1.28

promille

0.06

161

649

(3027923) C peptide [Moles/volume] in Serum or Plasma

132

494

2.69

24.60

1.3

1.5

1.33

1.30

nmol/l

0.13

104

367

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

300

1583

1.92

24.48

1.2

48.00

166.67

titre

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

452

2699

1.71

24.47

1.5

1.4

266.72

275.34

ug/g

0.38

258

1533

(3025468) Yersinia sp identified in Specimen by Organism specific culture

223

1058

2.13

24.44

1.4

1.5

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

299

1577

1.92

24.43

1.2

247.86

341.37

titre

0.20

139

(3024522) Salmonella sp identified in Specimen by Organism specific culture

229

1100

2.11

24.31

1.4

1.5

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2143

17296

1.30

24.04

1.6

1.5

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

174

752

2.34

23.93

1.4

103266.43

95065.17

e6/l

0.05

518

(3039162) Centromere protein B Ab [Units/volume] in Serum

236

1156

2.07

23.79

1.3

76.67

70.44

u/ml

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

222

1065

2.11

23.66

1.4

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

222

1065

2.11

23.66

1.4

1.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

406

2376

1.74

23.65

1.8

1.7

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

571

3655

1.59

23.52

3.7

3.4

25.63

25.25

mmol/l

1.70

529

3543

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

127

478

2.68

23.43

1.1

1.12

1.11

u/l

0.05

195

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

860

6020

1.47

23.36

3.0

3.6

4.50

4.51

pmol/l

0.13

768

5441

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3416

29267

1.25

23.31

5.6

5.1

2.25

2.66

ug/l

0.51

3163

26816

(3023419) Bacteria identified in Sputum by Culture

225

1095

2.08

23.10

2.9

2.5

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

133

517

2.59

23.01

1.3

1.2

0.71

0.76

ratio

0.12

293

(3009445) Proteinase 3 Ab [Units/volume] in Serum

594

3866

1.57

22.78

1.3

1.6

18.70

14.84

iu/ml

—

113

(3023520) Reticulocytes [#/volume] in Blood

1026

7463

1.42

22.63

2.5

2.6

68.56

70.52

e9/l

1.00

834

5371

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1428

10993

1.35

22.21

2.4

2.8

6.55

8.65

umol/l

5.22

1209

9677

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

510

3236

1.61

21.79

1.2

1.3

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

160

699

2.31

21.51

1.2

1.3

1.86

2.09

mmol/l

1.96

143

659

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

459

2868

1.63

20.89

1.6

1.7

1.21

1.20

g/l

0.43

431

2750

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1905

15398

1.29

20.73

3.1

3.6

0.82

mmol/l

0.52

1780

14608

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

157

692

2.29

20.70

1.2

1.1

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

763

5346

1.46

20.57

3.6

3.3

131.89

130.36

g/l

1.12

725

5211

(3025941) Bacteria identified in Stool by Culture

714

4941

1.48

20.51

1.3

1.2

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

486

3093

1.60

20.51

2.0

2.3

332.68

653.24

ug/l

1.88

460

2935

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

446

2781

1.63

20.47

1.6

1.7

0.24

g/l

0.22

417

2653

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

115

444

2.61

20.23

1.5

1.7

52.88

11.27

nmol/l

0.42

358

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

381

2292

1.69

20.10

1.8

1.6

—

(3011288) Drugs identified in Urine by Screen method Nominal

407

2500

1.65

19.83

3.1

—

(3029937) Albumin [Presence] in Urine by Test strip

3031

26000

1.23

19.63

4.5

3.9

0.00

estimate

0.06

996

9148

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

195

3.45

19.38

1.4

1.2

40.35

39.58

0.05

137

(1761482) Bacteria [#/volume] in Urine by Culture

318

1842

1.75

19.26

4.5

3.9

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

181

874

2.09

19.05

1.3

1.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

267

1474

1.83

19.01

1.4

1.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

302

1748

1.75

18.35

1.5

1.4

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

290

1660

1.77

18.32

1.8

1.6

—

(3038026) Centromere Ab [Units/volume] in Serum

144

646

2.25

18.26

1.2

61.36

44.98

u/ml

—

(3044927) Protein electrophoresis panel - Urine

161

757

2.14

18.18

1.2

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

106

418

2.55

17.91

2.1

2.0

97.38

150.50

umol/l

1.21

209

(3015377) Calcium [Moles/volume] in Serum or Plasma

3530

30968

1.21

17.90

2.9

3.7

2.35

2.36

mmol/l

1.80

3163

28363

(3009214) Lutropin [Units/volume] in Serum or Plasma

438

2821

1.58

17.60

1.5

1.4

10.52

10.23

u/l

0.17

361

2298

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

8211

78085

1.24

17.48

23.3

18.8

333.94

332.73

g/l

29.94

8185

77700

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

471

3093

1.55

17.37

2.3

8102.10

5218.30

u/l

0.75

147

1213

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1480

11835

1.29

17.20

5.3

6.2

1.04

1.03

mmol/l

0.63

1375

11098

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1131

8727

1.33

17.05

2.7

2.3

12.85

13.69

nmol/l

3.15

1017

8015

(3028026) IgM [Mass/volume] in Serum or Plasma

779

5675

1.40

16.90

2.0

1.9

1.39

1.32

g/l

0.28

721

5252

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

460

3031

1.54

16.72

1.6

1.5

11.43

0.23

iu/ml

0.49

570

(3027945) Reticulocytes/Erythrocytes in Blood

1238

9720

1.31

16.47

2.4

2.6

1.74

1.80

1.16

1099

8722

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

254

2.93

16.36

1.1

—

(4146454) Self-monitoring of blood glucose

168

842

2.01

16.06

2.9

2.6

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

518

3532

1.49

16.02

2.5

2.4

7.27

7.31

g/l

0.29

471

3262

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

517

3525

1.49

15.99

2.5

2.4

4.30

4.22

g/l

1.32

471

3257

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

516

3524

1.49

15.83

2.5

2.4

3.49

3.71

g/l

3.14

470

3258

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

118

518

2.29

15.82

1.1

2.72

10.04

nmol/l

1.20

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

296

1784

1.68

15.59

1.7

1.6

—

(3012544) pH of Venous blood

1126

8794

1.31

15.52

3.6

4.0

7.38

1.07

686

4911

(3033099) Centromere Ab [Titer] in Serum

219

3.03

15.50

1.1

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

940

7177

1.34

15.17

2.5

2.4

0.51

0.41

e6/l

0.25

901

6850

(3013139) Helicobacter pylori Ag [Presence] in Stool

847

6370

1.36

15.10

1.2

1.3

—

(3003129) Base excess in Capillary blood by calculation

187

996

1.89

15.00

2.6

2.2

0.28

0.61

mmol/l

0.67

182

961

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

877

6649

1.35

14.83

1.2

117.96

148.55

u/ml

1.77

346

2536

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

508

3518

1.47

14.54

2.1

1.9

39.23

40.81

nmol/l

0.89

494

3446

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

273

2.72

14.37

1.2

1.3

135.64

116.17

nmol/l

0.46

203

(3003694) ABO and Rh group [Type] in Blood

3096

27261

1.19

14.27

1.4

1.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

324

2052

1.60

14.04

1.9

2.2

131.79

130.65

g/l

0.36

271

1548

(44816559) Phosphatidylethanol [Mass/volume] in Blood

586

4196

1.42

14.03

2.0

1.8

0.33

mg/l

0.08

298

2087

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

170

3.19

13.90

5.7

7.3

10.79

10.74

0.05

170

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1167

9294

1.29

13.83

2.2

2.0

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

255

1530

1.68

13.71

1.1

1.2

0.87

0.97

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

240

1419

1.71

13.63

1.5

1.3

26.99

30.34

u/l

0.79

185

1166

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

405

2716

1.51

13.61

2.2

1.9

202.42

204.69

pmol/l

0.15

382

2600

(3004451) EKG impression Narrative

105

469

2.25

13.58

1.2

1.3

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

328

2.51

13.57

1.6

2.1

41.63

40.26

g/l

1.39

328

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1266

10211

1.27

13.54

2.2

2.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

226

2.84

13.51

1.2

1.3

38.77

38.97

g/l

0.03

117

(3026782) Osmolality of Urine

1990

16886

1.22

13.45

3.2

2.9

523.08

534.96

mosm/kgh2o

1.54

1763

14814

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

140

702

2.01

13.44

1.5

1.3

0.86

1.83

u/ml

1.39

403

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1101

8734

1.29

13.43

3.8

3.3

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2692

23517

1.20

13.38

4.8

4.1

21.69

21.86

0.23

1142

10834

(3024980) IgG subclass 4 [Mass/volume] in Serum

267

1641

1.64

13.10

1.7

1.6

0.73

0.77

g/l

0.25

173

1278

(4062490) Immunoglobulin typing, IgG

177

970

1.84

13.05

1.5

1.3

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

242

2.74

13.01

5.4

7.4

6.16

5.96

kpa

0.84

220

(3021589) Normoblasts [#/volume] in Blood

3754

41437

0.85

12.99

13.6

11.2

0.00

e9/l

2.67

3178

33587

(3017143) Hepatitis C virus Ab [Presence] in Serum

1365

11164

1.26

12.95

1.6

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

179

987

1.83

12.94

1.5

1.3

0.36

0.43

g/l

1.63

109

697

(3027135) IgG subclass 1 [Mass/volume] in Serum

179

987

1.83

12.94

1.5

1.3

6.58

6.87

g/l

0.42

109

699

(3028192) IgG subclass 2 [Mass/volume] in Serum

179

988

1.83

12.90

1.5

1.3

2.91

3.04

g/l

0.40

108

701

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1270

10319

1.26

12.74

3.8

4.8

232.99

240.20

u/l

1.28

1203

9835

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

108

505

2.15

12.52

1.4

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

217

1280

1.71

12.47

1.4

1.3

336.61

400.82

pmol/l

0.36

185

1088

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

125

619

2.03

12.46

2.7

2.8

213.57

240.50

e6/l

1.00

109

531

(3034860) Kappa light chains.free [Mass/volume] in Serum

417

2866

1.47

12.45

3.1

3.4

38.83

71.48

mg/l

1.05

354

2425

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

415

2864

1.47

12.14

3.1

3.4

33.28

44.95

mg/l

1.65

351

2426

(3038515) Glucose [Moles/volume] in Venous blood

258

1604

1.62

12.13

3.7

3.1

7.31

7.38

mmol/l

0.11

250

1559

(3038071) Oxygen [Partial pressure] in Mixed venous blood

219

2.75

11.96

5.3

7.6

5.42

5.45

kpa

0.03

219

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

108

515

2.11

11.93

1.4

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

151

3.12

11.75

1.1

0.53

0.70

umol/24h

2.25

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

221

1332

1.67

11.74

1.3

0.55

3.25

nmol/l

1.03

213

1290

(3000850) Epithelial cells [#/volume] in Urine

2278

19813

1.19

11.63

2.9

2.7

5.16

5.52

e6/l

0.67

2101

18001

(3052592) Norovirus Ag [Presence] in Stool

142

3.18

11.59

1.2

1.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

175

2.92

11.40

2.3

2.7

4.61

33.39

ug/l

0.76

175

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

214

1290

1.67

11.38

1.3

7.18

7.28

mmol/l

0.18

184

1149

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

631

4741

1.35

11.31

2.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

144

776

1.87

11.26

2.6

2.8

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

358

2437

1.49

11.25

1.1

1.2

3.48

3.78

0.35

409

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

133

700

1.91

11.18

1.6

2.1

18.09

17.98

nmol/l

0.06

122

668

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1192

9761

1.25

11.11

6.3

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

369

2537

1.47

11.04

2.3

2.1

11.27

11.63

mg/l

0.41

346

2374

(1001926) Buprenorphine [Presence] in Urine by Screen method

414

2913

1.44

10.97

2.7

2.2

—

(3011985) Renin [Units/volume] in Plasma

226

1396

1.63

10.95

1.4

1.5

50.70

55.71

mu/l

0.23

206

1260

(3019420) Tryptase [Mass/volume] in Serum or Plasma

107

527

2.04

10.89

1.6

7.37

7.96

ug/l

0.20

479

(3023323) Follitropin [Units/volume] in Serum or Plasma

677

5176

1.33

10.80

1.4

28.72

29.84

iu/l

0.38

602

4464

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

465

3355

1.40

10.71

2.5

2.4

2.60

2.91

g/l

10.43

417

3088

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

220

1361

1.63

10.61

1.3

0.24

nmol/l

0.01

100

(3008295) Osmolality of Serum or Plasma

166

955

1.75

10.50

1.4

276.25

278.93

mosm/kgh2o

0.85

127

751

(3028717) Thiamine [Mass/volume] in Blood

131

3.14

10.38

1.2

67.02

63.37

ug/l

0.54

131

(3021387) Prolactin [Units/volume] in Serum or Plasma

458

3317

1.40

10.33

1.6

1.7

249.15

294.70

mu/l

5.00

417

3016

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

425

3043

1.41

10.24

2.5

2.4

9.64

10.20

g/l

2.08

367

2754

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

357

2477

1.46

10.21

1.3

—

(3003181) Sodium [Moles/volume] in Urine

243

1560

1.57

10.06

1.4

61.07

62.06

mmol/l

0.15

203

1245

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

737

5772

1.30

9.89

2.2

2.0

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

361

2.20

9.80

1.0

1.1

154.05

445.77

ng/l

0.65

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

375

2648

1.43

9.78

2.1

3.38

5.87

iu/l

0.64

173

1135

(3037121) Protein [Mass/volume] in Urine

403

2888

1.41

9.69

3.3

3.4

897.84

385.90

mg/l

0.49

145

1351

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

319

2.27

9.63

1.2

0.31

0.30

g/l

0.76

253

(3016879) Cocaine [Presence] in Urine

477

3521

1.37

9.61

2.5

2.1

—

(3025577) Chromium [Mass/volume] in Blood

419

2.09

9.46

2.6

2.2

2.71

2.47

ug/l

0.14

360

(3017181) Myelocytes/Leukocytes in Blood

1004

8220

1.25

9.33

3.8

4.7

0.88

0.92

0.23

330

2478

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

171

1027

1.68

9.31

1.9

1.7

330.58

359.27

mu/l

0.35

132

818

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

113

602

1.89

9.24

2.3

2.7

567.52

522.68

e6/l

0.37

486

(3006576) Bicarbonate [Moles/volume] in Blood

275

2.34

9.20

5.2

7.0

25.03

25.17

mmol/l

0.11

253

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

156

918

1.71

9.17

1.9

1.8

—

(3049717) Cytology report of Urine Cyto stain

426

3114

1.38

9.13

2.5

2.6

—

(3000764) Benzodiazepines [Presence] in Urine

503

3775

1.35

9.13

2.5

2.1

—

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

347

2.17

9.06

2.1

2.0

29.10

29.26

0.03

336

(3003327) Ova and parasites identified in Stool by Light microscopy

454

3358

1.37

9.05

1.5

1.7

—

(3002032) Base excess in Venous blood by calculation

1023

8427

1.24

8.99

3.5

4.0

2.09

1.77

mmol/l

2.26

898

7456

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

181

1115

1.63

8.95

1.1

1.2

—

(3028300) Cannabinoids [Presence] in Urine

506

3813

1.34

8.95

2.5

2.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

3.83

8.93

1.2

1.58

1.66

umol/24h

0.21

(3002079) Sodium [Moles/time] in 24 hour Urine

449

2.01

8.93

1.1

1.3

169.55

165.54

mmol/24h

0.15

449

(3027008) Opiates [Presence] in Urine

504

3802

1.34

8.85

2.5

2.0

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

404

2945

1.39

8.82

1.9

1.8

—

(3040151) Glucose [Moles/volume] in Capillary blood

155

921

1.69

8.81

2.8

4.8

8.13

7.20

mmol/l

0.52

134

781

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

164

2.69

8.54

1.5

1.3

0.71

105.68

mg/l

1.43

120

(3020491) Glucose [Moles/volume] in Blood

110

597

1.85

8.53

2.0

1.9

6.45

6.55

mmol/l

0.18

432

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

486

1.94

8.45

1.2

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

344

2.13

8.45

2.5

2.3

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

432

3207

1.36

8.44

2.1

2.0

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1687

14661

1.18

8.40

1.6

1.7

—

(3026470) Cobalt [Mass/volume] in Blood

432

2.00

8.40

2.4

2.2

4.46

3.66

ug/l

0.24

404

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

673

0.27

8.39

28.9

15.0

862.17

2784.09

nmol/l

0.49

645

(3028707) Methadone [Presence] in Urine by Screen method

229

1514

1.52

8.39

3.6

2.9

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

298

2078

1.45

8.38

1.1

1.19

1.96

u/ml

1.25

160

1064

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

537

4129

1.32

8.28

4.4

4.0

48.29

48.32

0.01

530

4068

(3028626) Oxygen [Partial pressure] in Capillary blood

288

2001

1.45

8.26

2.5

3.0

8.17

8.21

kpa

0.18

283

1957

(3006245) CD3-CD19+ cells/cells in Blood

361

2.09

8.23

2.4

2.1

7.83

9.10

0.77

345

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

696

0.29

8.22

33.9

20.9

1395.30

2808.93

nmol/l

0.52

670

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

465

1.94

8.12

1.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1954

17229

1.17

8.10

1.9

—

(3002179) Metamyelocytes/Leukocytes in Blood

950

7858

1.23

8.02

3.5

4.5

0.79

0.69

0.46

325

2367

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

482

3668

1.33

8.00

1.6

17.24

16.45

u/ml

0.05

109

970

(3024869) Neuronal Ab [Presence] in Serum

153

2.69

7.96

1.0

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

264

1818

1.46

7.95

1.9

0.93

0.85

nmol/l

1.23

233

1564

(3027944) Amphetamines [Presence] in Urine

492

3762

1.32

7.91

1.9

2.0

—

(3021901) Oxygen saturation in Capillary blood

256

1756

1.47

7.87

2.5

3.0

90.09

90.28

0.16

249

1716

(3020961) Endomysium IgA Ab [Titer] in Serum

556

4330

1.30

7.82

1.1

110.00

182.88

titre

0.71

125

(3008037) Lactate [Moles/volume] in Venous blood

277

1935

1.44

7.75

3.6

3.0

1.49

1.54

mmol/l

0.48

271

1877

(3003888) Timothy IgE Ab [Units/volume] in Serum

263

1824

1.45

7.65

1.1

3.72

4.51

u/ml

0.46

124

945

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

119

685

1.75

7.64

2.0

2.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

275

2.19

7.49

6.4

2.8

4.94

4.89

kpa

0.15

275

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

276

2.18

7.43

6.4

2.8

10.63

10.30

kpa

0.37

276

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

179

1156

1.56

7.35

1.2

1.3

0.21

nmol/l

0.08

146

904

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

106

598

1.78

7.32

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

372

2.00

7.27

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

372

2.00

7.27

1.5

—

(3011412) CD3 cells [#/volume] in Blood

143

881

1.63

7.16

2.1

2.5

1303.38

1179.92

e6/l

0.96

124

782

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

349

2579

1.37

7.08

3.1

3.3

2.45

2.82

ratio

0.17

226

1429

(4015189) Microbial culture of sputum

193

2.39

7.07

1.9

2.0

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

104

592

1.76

6.98

1.2

—

(3009015) Lactate [Moles/volume] in Synovial fluid

3.29

6.95

1.2

7.53

5.81

mmol/l

0.46

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

165

2.49

6.89

1.0

1.1

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

305

2.07

6.88

1.1

1.2

106.41

110.58

0.59

274

(3013637) Mi-2 Ab [Presence] in Serum

246

2.20

6.87

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

246

2.20

6.87

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

246

2.20

6.87

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

246

2.20

6.87

1.1

—

(3025159) Blasts/Leukocytes in Blood

952

8001

1.21

6.86

4.0

4.9

0.27

0.40

0.32

275

2055

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

103

2.92

6.83

1.2

6.32

6.00

mmol/l

0.40

103

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

344

2555

1.36

6.78

1.4

1.5

10.88

12.47

iu/ml

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

137

848

1.62

6.76

2.0

1.9

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

322

2.03

6.68

2.1

2.0

97141.20

14828.73

u/ml

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

449

1.86

6.61

1.4

1.2

250.24

379.57

u/l

1.05

414

(3001186) Copper [Moles/volume] in Serum or Plasma

270

2.12

6.60

1.3

15.97

16.47

umol/l

0.39

231

(3017354) Segmented neutrophils/Leukocytes in Blood

145

918

1.59

6.54

3.4

3.8

57.37

57.02

0.08

131

798

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

137

857

1.61

6.50

1.2

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

203

1385

1.47

6.49

1.1

1.50

1.51

g/l

0.15

180

1267

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

598

4816

1.26

6.47

1.1

—

(3021440) Promyelocytes/Leukocytes in Blood

931

7852

1.20

6.47

3.9

4.7

0.10

0.11

255

2124

(21494755) Public health laboratory ask at order entry panel

899

10638

0.83

6.47

1.4

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

468

1.82

6.41

1.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

433

1.85

6.37

1.1

4.71

10.49

u/ml

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

552

1.75

6.27

2.5

2.9

42.02

40.09

0.45

292

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

337

1.96

6.26

2.2

2.1

68.22

60.86

ug/l

0.41

329

(3000492) Spirometry study

1150

9911

1.18

6.26

1.5

—

20.46

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

568

1.73

6.23

1.4

1.5

20.93

22.38

u/ml

0.11

(1616796) Gas panel - Central venous blood

268

1940

1.39

6.22

3.7

3.8

—

(3034891) Synovial lining cells/cells in Synovial fluid

401

1.88

6.22

1.8

1.5

2.71

3.66

0.20

(3006270) Folate [Moles/volume] in Blood

108

644

1.68

6.20

1.2

1.1

331.93

378.49

nmol/l

1.86

556

(3008401) Mugwort IgE Ab [Units/volume] in Serum

247

1770

1.41

6.09

1.1

0.61

1.13

u/ml

1.86

104

753

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

333

4383

0.75

6.08

1.1

1.2

0.91

0.89

g/l

0.68

333

4373

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

301

4017

0.74

6.05

1.1

0.66

0.64

ratio

0.16

530

(1175426) CD3 cells/Lymphocytes in Blood

119

733

1.63

6.04

1.9

2.1

74.12

73.32

0.25

108

710

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

128

2.58

6.02

2.2

1.9

—

(4034850) Laboratory test

188

2706

0.69

5.99

9.4

8.8

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

336

1.94

5.97

1.2

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

124

774

1.61

5.97

1.2

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1011

8654

1.19

5.96

3.6

3.9

5.84

5.80

kpa

0.72

982

8450

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

2.98

5.94

1.4

28.92

14.89

pmol/l

0.27

(4094501) Cardiovascular stress test using bicycle ergometer

360

2752

1.32

5.89

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

317

1.96

5.89

1.1

95.59

87.96

1.95

151

(3025018) Bordetella pertussis Ab [Titer] in Serum

108

654

1.66

5.87

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1594

17889

0.87

5.87

3.1

0.69

0.74

ug/l

1.60

972

11023

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

542

1.72

5.83

1.7

2.0

88.88

106.35

ng/l

1.31

542

(3003329) Lymphocytes/Leukocytes in Synovial fluid

117

725

1.62

5.82

1.8

1.5

27.76

30.70

0.35

425

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

150

985

1.53

5.81

1.2

1.1

—

2.21

—

(3010838) Calcium [Moles/time] in 24 hour Urine

233

1672

1.40

5.73

1.9

4.77

5.19

mmol/24h

1.30

207

1497

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

384

1.85

5.71

1.1

2.42

8.95

u/ml

—

(3032057) Clostridioides difficile [Presence] in Stool

156

2.38

5.69

1.7

2.0

—

(3028271) Lactate [Moles/volume] in Capillary blood

192

1339

1.44

5.55

2.0

1.8

1.63

1.71

mmol/l

0.63

192

1306

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

122

2.55

5.52

2.3

1.9

—

(40762814) Titanium [Mass/volume] in Blood

105

2.67

5.48

2.5

2.52

4.19

ug/l

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1029

8886

1.18

5.47

2.2

2.3

0.22

0.21

g/l

4.60

935

8319

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1208

10576

1.16

5.39

1.5

1.4

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

465

1.75

5.39

1.5

1.3

4.06

4.65

umol/l

0.82

412

(3029075) Extractable nuclear Ab panel - Serum

587

1.66

5.33

1.1

—

0.40

—

(3014271) Vancomycin [Susceptibility]

302

1.93

5.27

2.8

2.9

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

470

1.73

5.20

1.1

1.2

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

123

794

1.56

5.20

1.1

1.0

288.62

285.98

mg/l

0.18

108

720

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

311

1.90

5.18

1.1

1.2

102.93

88.15

3.14

149

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1071

12255

0.86

5.14

2.0

3.65

3.53

ratio

0.98

834

9519

(40759836) Histone Ab [Presence] in Serum by Immunoblot

118

757

1.57

5.13

1.2

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

633

7565

0.83

5.08

2.1

2.7

68.85

68.74

ml/min/173m2

0.02

275

3137

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

111

704

1.58

5.07

1.9

2.1

14.83

15.24

0.16

103

693

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

557

1.66

5.07

1.3

1.2

1.06

ratio

0.31

461

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

321

1.87

5.04

1.1

1.2

116.73

105.93

1.31

296

(40760892) CBC W Ordered Manual Differential panel - Blood

2340

21474

1.12

5.01

4.5

4.7

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

390

3088

1.27

4.95

2.8

2.4

0.80

0.82

g/l

0.04

337

2682

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

187

1330

1.41

4.90

1.1

2.63

2.55

0.04

269

(3008757) Leukocyte morphology finding [Identifier] in Blood

125

823

1.53

4.86

3.4

4.0

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

283

1.91

4.84

1.3

1.2

17.17

20.59

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

117

764

1.54

4.74

1.2

114.74

112.57

pmol/l

0.19

117

764

(44813793) Dust mix specific IgE antibody measurement

101

638

1.59

4.72

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

300

1.87

4.71

1.4

1.5

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

820

7040

1.18

4.70

3.6

3.9

1.23

mmol/l

0.70

702

6099

(3004809) Band form neutrophils/Leukocytes in Blood

197

1425

1.39

4.70

3.1

3.7

1.26

1.66

0.85

181

1288

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

279

2132

1.32

4.66

2.1

1.8

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

396

1.75

4.65

2.4

51.25

50.66

umol/l

0.04

353

(3042010) Triglyceride [Moles/volume] in Pleural fluid

122

2.38

4.54

1.5

1.3

1.47

1.91

mmol/l

0.13

(4211845) Urine protein measurement

407

1.72

4.52

2.9

3.0

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

335

1.80

4.45

1.4

72.05

289.11

nmol/24h

1.52

335

(4035726) Immunohistochemistry procedure

716

8356

0.85

4.42

1.3

1.4

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

192

1399

1.38

4.41

1.3

1.2

—

(3012501) Base excess in Blood by calculation

241

1820

1.33

4.40

4.5

4.0

2.49

2.51

mmol/l

0.04

175

1224

(3004775) Volume in Urine collected for unspecified duration

588

1.59

4.36

2.2

607.87

663.90

0.79

410

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

113

747

1.52

4.36

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

111

731

1.52

4.36

1.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1582

17453

0.89

4.36

2.6

3.1

2.44

2.45

mmol/l

2.05

1408

15743

(3040893) Potassium [Moles/volume] in Capillary blood

7.51

4.35

1.4

1.5

4.28

4.54

mmol/l

—

(3023183) Ammonium ion [Moles/volume] in Plasma

257

1963

1.32

4.34

2.3

2.9

29.07

34.93

umol/l

3.56

227

1783

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

217

1.99

4.34

1.7

1.6

0.47

0.40

ug/l

0.45

159

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

113

748

1.52

4.33

1.2

—

(4281824) Cell count and differential, peritoneal fluid

1091

0.59

4.33

1.1

1.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.88

4.32

6.3

6.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

184

1337

1.38

4.31

1.1

2.37

3.87

eliau/ml

1.83

679

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

413

1.70

4.31

1.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

481

3966

1.22

4.30

1.6

1.7

1.55

1.54

g/l

0.06

423

3429

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

462

1.65

4.19

1.5

2.2

138.31

150.88

0.85

437

(40768800) Prostate Pathology biopsy report

132

1888

0.70

4.19

1.3

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

109

2.39

4.13

1.1

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

607

5143

1.19

4.09

1.8

1.7

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.63

4.05

1.1

1.0

0.07

0.02

u/ml

1.27

(3042517) Benzodiazepines panel - Urine

104

2.41

4.04

1.6

2.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

164

1185

1.39

4.00

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

105

698

1.51

3.98

1.1

7.52

8.15

iu/ml

0.08

203

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

311

1.77

3.96

1.1

—

(3006462) Nitrate [Presence] in Urine

372

1.70

3.90

3.1

3.2

—

(40757373) Influenza virus identified in Isolate

145

2.14

3.85

1.3

1.7

—

(3033658) Prothrombin time (PT) actual/Normal

2579

24066

1.10

3.84

3.8

4.1

95.94

90.82

25.64

2495

23565

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

113

2.30

3.84

1.2

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

499

1.59

3.78

1.3

84.00

59.74

titre

—

(40761536) Microorganisms panel - Urine sediment

826

7232

1.15

3.73

4.8

3.8

—

(4198724) Urine methamphetamine measurement

408

1.65

3.72

2.0

2.4

—

(3000034) Microalbumin [Mass/volume] in Urine

110

750

1.47

3.72

2.7

2.8

23.24

59.69

mg/l

1.62

547

(3041918) Cholesterol [Moles/volume] in Pleural fluid

154

2.08

3.71

1.4

1.2

2.08

1.73

mmol/l

0.71

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

216

1.90

3.70

2.0

14.25

17.29

umol/l

1.11

216

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

479

1.59

3.68

1.2

6.76

10.35

mm/h

3.43

479

(3018333) Ribosomal P Ab [Presence] in Serum

104

703

1.48

3.67

1.2

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

104

705

1.48

3.63

1.9

1.6

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

214

1639

1.31

3.61

1.1

15.28

13.50

au/ml

0.12

473

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

299

1.74

3.57

1.3

1.5

13.94

15.28

pmol/l

0.87

250

(3016750) Collection duration of Urine

429

1.61

3.54

2.0

2.2

499.61

494.66

min

0.15

331

(3045683) HLA typing for celiac disease panel - Blood or Tissue

556

1.53

3.52

1.0

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

105

718

1.47

3.52

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

200

1524

1.32

3.52

1.0

1.1

3.06

3.12

u/ml

0.03

100

730

(42528597) U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum by Line blot

6.16

3.50

1.0

1.1

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

6.16

3.50

1.0

1.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

786

6895

1.15

3.47

2.4

2.2

6.29

8.40

ug/l

2.10

671

6137

(3007566) Smooth muscle Ab [Titer] in Serum

350

2865

1.23

3.43

1.2

1.3

76.83

139.66

titre

1.93

292

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

342

1.67

3.38

1.9

2.1

6.93

9.54

mg/l

4.36

289

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

815

9223

0.87

3.38

2.7

2.6

32.60

41.09

u/l

2.97

675

7884

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

134

2.09

3.32

1.0

1.1

—

51.16

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

211

1.85

3.29

1.0

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

189

1444

1.31

3.29

1.0

1.1

3.18

3.64

u/ml

0.17

622

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

800

9046

0.87

3.28

1.7

3.50

3.52

mmol/l

0.16

554

6275

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

211

1638

1.29

3.27

1.5

1.2

26.24

31.14

u/l

0.40

183

1418

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

447

1.57

3.25

1.3

—

(3002582) Erythrocytes [#/volume] in Urine

3101

29344

1.08

3.24

3.8

3.3

40.23

73.29

e6/l

3.02

2508

22019

(3042631) Mycobacterium sp identified in Specimen

152

1128

1.35

3.23

2.7

—

(3016038) Potassium [Moles/volume] in Urine

560

1.50

3.22

1.2

29.90

35.05

mmol/l

1.40

499

(3011841) English Walnut IgE Ab [Units/volume] in Serum

2.58

3.20

1.0

0.02

0.31

u/ml

1.35

(3038177) Helicobacter pylori Ab [Presence] in Serum

212

1652

1.29

3.20

1.2

—

(3034770) Mitochondria Ab [Titer] in Serum

344

2835

1.22

3.19

1.2

1.3

952.22

869.67

titre

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

238

1884

1.27

3.17

1.4

1.6

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

212

1657

1.29

3.13

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.63

3.12

2.6

1.6

59.63

43.82

umol/l

1.19

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

390

1.59

3.09

1.1

95.18

96.55

0.15

318

(3034274) Bile acid [Moles/volume] in Serum --fasting

140

1034

1.36

3.08

2.0

7.92

7.56

umol/l

0.07

105

750

(36304419) Bacteria [Presence] in Urine

2579

24276

1.08

3.06

3.5

3.1

53.43

203.16

estimate

0.39

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

292

3565

0.81

3.03

1.5

1.6

981.52

1014.37

mu/l

0.16

230

2956

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

2.26

3.02

1.0

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

190

1477

1.29

2.95

1.1

127.90

117.01

4.80

170

1350

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

220

1.78

2.92

1.0

1.1

—

(3022806) Fractional oxyhemoglobin in Capillary blood

139

1036

1.35

2.91

2.0

1.8

90.09

89.78

0.29

139

1021

(3048929) Epstein Barr virus Ab [Presence] in Serum

359

3004

1.20

2.88

1.3

1.2

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

510

1.49

2.87

1.5

3707588.00

1040161.29

iu/ml

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

5.39

2.86

1.0

1.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

430

1.54

2.85

1.2

1.7

2.12

1.94

umol/l

1.23

392

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

230

1.74

2.82

1.0

1.1

—

(3023410) Appearance of Cerebral spinal fluid

128

948

1.35

2.81

1.3

1.5

—

(40768443) Skin Pathology biopsy report

490

4226

1.17

2.78

1.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.26

2.76

1.0

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

148

1124

1.32

2.75

1.5

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

216

1724

1.26

2.74

1.1

2.10

1.44

u/ml

0.34

109

843

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.43

2.70

1.2

1.1

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

125

2.00

2.69

1.0

0.03

1.31

u/ml

0.93

(3028433) Virus identified in Specimen by Culture

279

1.65

2.69

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

497

4307

1.16

2.66

1.4

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

220

1.73

2.63

1.0

1.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

3.60

2.57

3.6

4.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

728

0.63

2.56

1.1

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

185

1.79

2.56

1.0

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

201

1.74

2.51

1.0

1.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

2319

21900

1.08

2.48

4.2

3.6

0.00

0.46

1.13

197

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

2.97

2.48

1.4

1.2

2.36

1.68

mg/l

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.46

2.48

1.0

—

(3044009) aPTT.lupus sensitive (LA screen)

2.32

2.48

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

195

1.75

2.45

1.1

1.2

—

(4133840) Spirometry

264

1.63

2.43

1.1

1.2

—

(40768793) Breast Pathology biopsy report

184

2294

0.80

2.40

1.3

—

(1761868) Lipid panel - Serum or Plasma

3814

39638

0.94

2.39

3.4

3.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

289

1.59

2.38

1.0

0.23

0.61

u/ml

0.65

283

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

205

1657

1.24

2.38

1.1

—

(3048879) Bone marrow aspiration report

220

1.68

2.36

2.0

2.1

—

2.00

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

2.06

2.36

1.3

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.50

2.35

1.2

1.0

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.50

2.35

1.0

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

175

1392

1.26

2.34

3.3

3.1

0.78

0.81

nmol/l

0.56

139

1108

(3043238) Trisomy 21 risk [Likelihood] in Fetus

129

1673

0.77

2.34

1.5

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

103

762

1.36

2.34

2.0

1.9

3.39

3.92

mg/l

0.54

734

(3035947) Staphylolysin Ab [Units/volume] in Serum

395

1.50

2.32

1.2

1.1

3.57

3.67

iu/ml

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

106

789

1.35

2.32

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

125

1623

0.77

2.29

1.5

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

8905

87959

1.09

2.29

16.4

14.5

83.61

83.19

ml/min/173m2

1.24

8378

81108

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

166

2081

0.79

2.29

1.4

1.5

65.32

61.53

ug/l

0.15

127

1712

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

194

1566

1.24

2.29

1.9

1.8

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

253

2101

1.21

2.28

5.8

6.0

499.60

1968.85

iu/ml

1.00

309

(3014576) Chloride [Moles/volume] in Serum or Plasma

1340

12430

1.09

2.25

6.3

7.9

104.32

104.48

mmol/l

0.60

1340

12425

(3000060) B lymphocytes [#/volume] in Blood

262

1.61

2.25

2.2

2.0

0.13

0.23

e9/l

0.56

126

(3012920) Ethanol [Mass/volume] in Serum or Plasma

3.89

2.25

1.0

1.4

1.43

2.33

g/l

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

186

1.72

2.23

1.2

1.3

—

(1617658) Protocol used for examination of sentinel lymph nodes

727

0.66

2.23

1.0

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

217

1.66

2.21

1.1

0.73

2.30

u/ml

0.84

109

(3005033) Fetal Nuchal fold Thickness US

124

1600

0.77

2.19

1.4

1.5

1.33

1.26

0.49

1139

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

165

1318

1.26

2.16

1.0

0.08

0.50

u/ml

2.06

406

(3024354) Oxygen [Partial pressure] in Venous blood

789

7153

1.11

2.15

3.2

4.59

4.62

kpa

0.15

767

6962

(40768806) Pleura Pathology biopsy report

886

0.70

2.14

1.7

1.5

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

2.16

2.14

1.0

0.03

0.02

u/ml

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

364

1.49

2.08

1.1

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

2.14

2.08

1.0

0.02

0.06

u/ml

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

332

1.51

2.07

2.5

2.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

332

1.51

2.07

2.5

2.4

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

2.70

2.06

1.1

1.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

431

1.44

2.05

1.5

1.8

3.32

1.69

u/ml

0.32

130

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.98

2.04

1.0

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

334

1.50

2.02

2.6

2.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

838

7649

1.10

2.02

1.4

1.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

450

1.42

2.00

2.2

2.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

450

1.42

2.00

2.2

2.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

450

1.42

2.00

2.2

2.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

451

1.42

1.98

2.2

2.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

224

1.61

1.98

2.3

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

544

1.38

1.97

1.1

1417.36

1538.83

miu/ml

0.44

544

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

119

1.85

1.96

1.0

1.1

0.01

0.33

u/ml

0.87

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

461

1.41

1.95

1.8

2.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

218

1817

1.20

1.94

2.1

2.3

112.95

103.66

ug/min

0.10

127

1104

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

198

1635

1.22

1.94

2.8

370.07

1679.61

u/ml

1.45

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

446

1.42

1.92

1.3

1.6

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

2.11

1.91

1.0

0.01

1.11

u/ml

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

605

0.66

1.89

1.2

86.22

89.77

u/l

0.09

506

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

471

0.61

1.89

1.0

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

106

817

1.30

1.88

1.4

1.3

153.96

180.14

pmol/l

0.98

106

817

(4195642) Thrombophilia screening test

179

1470

1.22

1.87

1.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

184

1516

1.22

1.86

1.1

87.19

7727.06

iu/ml

0.56

315

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

590

0.66

1.86

1.2

20.65

23.79

u/l

0.18

483

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.03

1.85

1.0

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

104

803

1.30

1.83

1.1

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

579

1.35

1.81

1.3

2.2

115.49

96.91

3.22

547

(3007542) Rye IgE Ab [Units/volume] in Serum

2.27

1.80

1.1

1.0

1.19

0.88

u/ml

—

(3019174) dRVVT (LA screen)

2.06

1.80

1.1

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

278

2388

1.17

1.78

1.2

—

(3002619) Bacteria identified in Specimen by Culture

231

1.56

1.78

1.4

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

590

1.34

1.77

1.5

1.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

111

871

1.28

1.75

1.9

2.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

257

1.52

1.72

1.2

1.3

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.67

1.72

1.1

1.0

0.05

0.04

u/ml

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

3.85

1.71

1.0

1.1

0.02

0.93

u/ml

—

(40762887) Creatinine [Moles/volume] in Blood

2.13

1.71

2.0

1.5

—

(42529406) Shigella sp [Presence] in Stool by Culture

278

2398

1.16

1.70

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

307

1.47

1.69

1.1

1.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.91

1.69

1.2

1.1

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

914

0.74

1.69

3.2

4.2

32.15

54.32

u/ml

1.50

906

(3028308) Erythrocytes [#/volume] in Pleural fluid

868

0.74

1.68

1.5

33107.38

50070.87

e6/l

0.48

468

(3027231) Wheat IgE Ab [Units/volume] in Serum

156

1.67

1.68

1.0

2.14

2.74

u/ml

0.10

134

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

243

1.52

1.67

1.7

152.19

110.73

au/ml

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

945

0.75

1.65

1.3

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

401

1.40

1.64

3.5

3.9

—

(3002256) Pathology report gross observation

1185

12648

0.93

1.64

1.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

651

1.31

1.63

1.7

—

(3020779) Urea [Moles/volume] in Serum or Plasma

871

8060

1.09

1.61

7.0

7.8

9.25

9.38

mmol/l

0.24

836

7741

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

274

2374

1.16

1.60

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

126

1017

1.24

1.59

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

406

1.38

1.54

1.6

1.7

2.83

2.70

u/field

0.04

301

(37208534) Antinuclear antibody arbitrary concentration in serum

289

1.46

1.54

1.1

—

(3018001) Oat IgE Ab [Units/volume] in Serum

2.03

1.53

1.2

1.0

0.12

0.17

u/ml

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

122

1497

0.81

1.50

1.7

1.8

—

(3023199) Leukocytes [#/volume] in Pleural fluid

984

0.77

1.48

1.5

3023.33

3393.83

e6/l

0.10

662

(3001556) Androgen free Index in Serum or Plasma

1.95

1.48

1.1

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

400

3578

1.12

1.47

1.7

5.91

4.43

mg/l

0.98

313

2609

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

236

2040

1.16

1.45

1.2

71.66

56.74

u/ml

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

2.37

1.45

1.1

1.2

0.03

0.71

u/ml

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

132

1.67

1.45

1.4

1.3

28.77

102.02

ng/l

1.91

(3007463) Buprenorphine [Presence] in Urine

2.50

1.45

2.3

8.5

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

3.13

1.44

4.4

6.9

0.51

0.23

mmol/l

—

(3016330) Potassium [Moles/time] in 24 hour Urine

125

1.68

1.43

1.1

1.3

—

79.26

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

221

1904

1.16

1.43

1.2

1.3

257.23

273.65

u/ml

0.27

149

1217

(3045788) Cell count panel - Pleural fluid

807

0.75

1.41

1.5

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

187

1592

1.18

1.40

1.5

1.4

0.33

0.38

nmol/l

0.62

148

1197

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

165

1.58

1.39

1.0

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

632

1.28

1.39

1.0

300.34

318.59

ng/l

0.26

472

(3020874) Milk IgE Ab [Units/volume] in Serum

616

1.28

1.37

1.0

0.65

1.49

u/ml

0.59

175

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.61

1.36

1.0

2.31

1.71

u/ml

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

179

1524

1.18

1.35

1.1

—

(3030467) Casts [#/volume] in Urine by Automated count

2639

25464

1.05

1.34

3.6

3.2

0.32

0.42

e6/l

1.73

2072

18249

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

265

1.44

1.33

2.3

3.3

28.62

28.70

umol/l

0.01

191

(40757494) Bilirubin.total [Moles/volume] in Blood

401

1.35

1.32

1.9

2.5

24.08

35.37

umol/l

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

594

1.28

1.31

1.8

1.9

1.37

1.43

u/field

0.05

323

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

631

1.27

1.29

1.0

752.48

745.81

ng/l

0.05

453

(37021550) Renin [Units/volume] in Plasma --upright

169

1.54

1.28

1.4

1.3

63.76

48.50

mu/l

0.13

129

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

114

1.67

1.28

1.3

0.33

0.27

nmol/l

0.17

(3000991) Gas panel - Venous blood

731

7858

0.93

1.27

7.4

9.9

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

633

1.27

1.26

1.1

1.0

40.05

39.23

ng/l

0.06

464

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

278

1.40

1.24

1.1

1.0

6.02

10.85

u/ml

0.92

195

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

1089

0.81

1.23

1.4

4.54

3.63

ug/l

0.30

940

(3007700) Barley IgE Ab [Units/volume] in Serum

2.04

1.21

1.1

1.0

0.17

1.08

u/ml

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

116

1.64

1.21

1.0

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

540

1.28

1.20

1.5

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

109

1.65

1.18

1.0

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.70

1.17

1.0

1.1

0.99

0.78

u/ml

0.11

(3001019) Free T4 and TSH panel - Serum or Plasma

491

5341

0.92

1.15

1.6

1.7

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1000

9439

1.07

1.15

3.3

4.6

14.04

27.73

ug/l

1.10

791

7614

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

292

2613

1.12

1.14

1.9

1.7

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

168

1943

0.86

1.13

1.4

1.5

1.13

1.16

ratio

0.10

1165

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

301

1.36

1.12

1.1

1.2

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.96

1.11

7.1

4.5

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

556

6002

0.92

1.10

8.2

10.7

1.38

1.33

0.55

550

5969

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

167

1926

0.86

1.09

1.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

105

1258

0.83

1.09

1.5

62.48

60.92

ug/l

0.12

105

1258

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

2.38

1.09

1.6

1.0

300.40

261.00

u/ml

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

653

6087

1.08

6.8

8.7

25.08

24.77

mmol/l

1.67

648

6050

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

177

1.47

1.07

1.1

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

177

1.47

1.07

1.1

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

177

1.47

1.07

1.1

1.2

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.87

1.07

1.1

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

347

1.33

1.07

1.9

1.8

—

(3020876) Protein [Mass/time] in 24 hour Urine

128

1087

1.18

1.06

2.6

2.4

1.39

1.28

g/24h

0.14

651

(3045142) Bone marrow Pathology biopsy report

1068

0.82

1.06

1.5

1.4

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

105

1.62

1.05

1.0

1.1

—

(40768795) Lymph node Pathology biopsy report

991

0.82

1.05

1.2

1.3

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

302

0.66

1.05

2.7

1.9

35390.30

14510.24

e6/l

—

144

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.96

1.03

3.9

6.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

187

1.45

1.03

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

562

1.25

1.02

1.5

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

170

1946

0.87

1.02

1.4

1.5

1.14

1.21

ratio

0.46

1173

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

170

1946

0.87

1.02

1.4

1.5

1.05

0.95

ratio

0.93

1168

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

100

835

1.20

1.01

3.4

3.8

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

137

1177

1.17

1.00

1.7

1.5

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.80

0.98

1.3

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.80

0.96

1.0

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

100

1.60

0.96

1.0

1.1

—

(3024263) Appearance of Synovial fluid

433

1.27

0.96

1.7

—

(3013762) Body weight Measured

0.00

0.95

0.0

1.3

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

263

2914

0.90

0.95

2.1

2.6

3.57

3.62

g/l

0.21

243

2787

(44806071) Cardiolipin IgM antibody measurement

141

1.49

0.94

1.2

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.77

0.94

1.0

0.06

0.16

u/ml

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

191

1.41

0.94

2.2

5.3

48.00

60.05

u/l

0.50

185

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

317

0.69

0.94

1.2

69.32

66.68

u/ml

0.05

310

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

107

907

1.18

0.93

4.7

5.5

246.40

73.94

u/ml

0.73

295

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

542

5810

0.93

8.4

11.0

0.69

0.63

2.79

536

5780

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

2.22

0.93

1.0

1.2

—

(4038314) Semen analysis, post vasectomy

1.82

0.92

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

315

3451

0.91

0.92

1.5

1.4

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

498

0.76

0.91

1.3

1.5

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

170

1498

1.14

0.90

1.8

1.7

—

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

1.75

0.90

1.0

1.3

—

16.59

—

(3020650) Glucose [Presence] in Urine

359

1.28

0.88

1.7

1.6

0.02

0.04

estimate

0.31

359

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

119

1.51

0.87

1.9

2.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.79

0.87

1.8

—

(3019832) Treponema pallidum Ab [Presence] in Serum

901

8564

1.06

0.87

1.7

1.8

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

2.00

0.87

1.2

1.1

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

1.72

0.86

1.5

1.6

0.41

0.87

mg/l

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

1.72

0.86

1.5

1.6

1.18

2.20

mg/l

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

1.72

0.86

1.5

1.6

2.81

2.13

mg/l

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

1.72

0.86

1.5

1.6

1.73

4.34

mg/l

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

291

2654

1.10

0.86

2.5

2.3

0.02

g/l

0.06

263

2408

(40768446) Kidney Pathology biopsy report

402

0.75

0.85

1.6

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.56

0.84

1.9

2.1

—

(3019230) Fractional oxyhemoglobin in Venous blood

180

2019

0.89

0.84

2.6

2.9

60.80

63.03

0.73

180

2013

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

274

1.31

0.83

1.5

1.6

9.40

8.93

ug/l

0.22

274

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.74

0.82

1.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

138

1.45

0.81

2.2

2.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

736

1.18

0.81

2.0

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

736

1.18

0.81

2.0

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

736

1.18

0.81

2.0

1.8

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

155

1.42

0.80

1.3

1.5

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

189

1.38

0.80

1.4

1.2

414.05

297.86

pmol/l

0.47

144

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

302

3287

0.92

0.79

1.3

1.4

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

164

1.40

0.79

2.0

2.2

7.37

8.09

mmol/l

0.30

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

119

1364

0.87

0.79

2.4

2.8

111.39

949.34

u/ml

0.67

119

1347

(3009466) Valproate [Moles/volume] in Serum or Plasma

153

1355

1.13

0.78

4.2

5.8

342.50

365.05

umol/l

1.14

130

1171

(40768441) Liver Pathology biopsy report

772

0.83

0.78

1.3

1.4

—

(3018095) Leukocytes [#/volume] in Urine

3453

33830

1.03

0.78

4.3

3.9

67.49

88.96

e6/l

1.40

2648

23417

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.56

0.78

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.77

0.0

2.1

—

279.89

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

121

1057

1.15

0.76

1.6

1.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

123

1077

1.14

0.75

1.2

1.1

—

(3042733) HLA Ab [Presence] in Serum

348

0.75

5.0

5.2

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

131

1153

1.14

0.75

1.2

1.1

104.56

97.15

2.67

124

1084

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

277

2543

1.09

0.74

2.5

2.4

0.00

g/l

0.80

245

2256

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.64

0.73

1.0

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

285

3094

0.92

0.73

1.7

2.2

98.40

93.18

4.15

271

2992

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

124

1093

1.14

0.71

3.3

3.6

49.65

11.25

nmol/l

0.38

116

1066

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.64

0.68

1.0

1.8

—

(3002523) Influenza virus A Ag [Presence] in Specimen

213

1942

1.10

0.68

1.2

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.51

0.66

1.0

—

(3051611) Lipemic interference index of Serum or Plasma

863

0.86

0.65

3.8

3.3

18.70

13.17

index

1.07

514

(3028679) Herpes simplex virus Ab [Presence] in Serum

513

1.19

0.65

1.2

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

662

1.16

0.64

1.5

1.4

—

(3024932) HLA-DR beta [Type]

315

0.76

0.63

1.2

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

333

3107

1.07

0.63

1.3

181.09

225.81

miu/ml

1.61

145

1416

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

225

1.29

0.62

1.4

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

212

1944

1.09

0.62

1.2

1.1

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

101

0.59

0.62

3.3

3.0

1.22

1.05

mg/l

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.63

0.62

1.9

1.6

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.63

0.62

1.1

1.4

—

(3046861) Legionella sp Ag [Presence] in Urine

1.60

0.61

1.1

1.0

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

368

0.79

0.60

1.5

2.8

0.63

0.61

mmol/l

0.64

368

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.48

0.60

1.0

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

218

2005

1.09

0.60

1.4

15.28

22.44

u/ml

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.57

0.60

1.1

1.0

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

368

3454

1.07

0.60

2.5

3.8

417.24

2215.70

u/ml

1.35

308

2976

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.59

0.0

1.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

310

2895

1.07

0.59

1.5

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

268

2882

0.93

0.58

2.0

2.5

170.98

192.16

3.73

249

2742

(1002224) Polysomnography panel

504

5309

0.95

0.58

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.56

0.58

1.0

1.1

5.30

13.98

u/l

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.58

0.0

5.9

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

715

1.15

0.58

1.5

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

354

0.79

0.57

2.4

2.1

42092.90

802.77

e6/l

0.75

234

(40761995) Spermatozoa Progressive [#/volume] in Semen

219

0.73

0.57

4.3

3.2

49.81

43.52

0.43

219

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.48

0.57

1.0

1.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.48

0.57

1.5

458.60

492.21

nmol/l

—

(40758358) Immune stain study

1.67

0.56

1.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

265

2466

1.08

0.56

1.2

1.3

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

238

1.26

0.56

1.4

1.3

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.57

0.56

2.4

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

218

0.73

0.56

8.4

6.4

8.19

8.79

0.22

218

(3024471) HLA-A [Type]

319

0.78

0.56

1.0

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.62

0.55

1.3

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

199

1834

1.09

0.54

1.4

1.5

161.65

150.79

au/ml

0.70

535

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

256

2384

1.08

0.54

2.6

2.4

0.00

g/l

-0.00

242

2253

(3009677) Dengue virus Ab [Presence] in Serum

1.58

0.54

1.0

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

142

1.34

0.54

1.1

1.0

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

272

0.77

0.53

1.1

1.5

11.36

12.78

g/l

0.26

204

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.54

0.53

1.0

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

313

2940

1.07

0.52

2.7

3.0

1.57

1.49

mg/l

0.81

283

2722

(43055514) Macroprolactin [Presence] in Serum or Plasma

214

1.26

0.52

1.1

1.4

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.50

0.51

1.0

—

(40763590) HLA-DQ beta [Type]

1.46

0.50

1.0

—

(40758292) HTLV I+II Ab panel - Serum

216

1.25

0.49

1.5

1.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

248

2322

1.07

0.47

1.3

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.46

0.46

2.0

1.5

—

(3000012) Reticulocyte production index

133

1216

1.09

0.46

1.7

2.1

0.93

0.91

0.14

812

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

215

2008

1.07

0.45

1.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

101

912

1.11

0.45

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

301

1.20

0.45

1.1

—

(4268621) Lupus anticoagulant assay

124

1132

1.10

0.45

2.3

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

808

1.11

0.44

1.3

8.71

8.82

mmol/l

0.08

760

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

319

0.81

0.44

2.7

2.6

53.84

159.05

au/ml

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

170

1575

1.08

0.44

1.3

1.2

6.14

4.03

u/ml

0.68

727

(40765089) Chromosome analysis panel - Blood by G-banded

264

0.80

0.44

1.0

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

348

1.18

0.44

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

507

1.14

0.43

1.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

166

1.27

0.43

1.4

1.9

—

(3005011) Chlamydia sp Ab [Titer] in Serum

131

0.69

0.43

1.9

1.6

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

678

1.12

0.42

1.1

—

0.64

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.41

0.0

1.0

—

0.40

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.41

0.0

1.0

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

0.40

0.0

2.2

—

29.52

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

389

1.16

0.40

1.2

5.4

4997.46

1731.66

mg/l

0.28

282

(3035320) C reactive protein [Mass/volume] in Body fluid

710

1.11

0.40

3.2

2.6

23.89

30.14

mg/l

0.88

514

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

141

1.28

0.40

1.0

24.93

7.51

u/ml

0.38

141

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

267

2820

0.95

0.39

3.2

0.37

0.34

iu/ml

0.77

165

1533

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.31

0.39

1.0

1.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

598

1.12

0.38

1.0

3.89

0.73

u/ml

0.46

123

(3001964) Herpes simplex virus Ag [Presence] in Specimen

242

1.20

0.38

1.5

—

(3022475) Manganese [Moles/volume] in Blood

1.34

0.38

1.2

1.3

0.12

0.17

umol/l

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

999

0.91

0.38

1.2

53.77

60.98

u/l

0.91

868

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

234

1.20

0.37

1.3

1.2

12.28

11.85

pmol/l

0.03

(3022229) Phosphate [Moles/volume] in Urine

1.35

0.37

1.0

1.3

30.48

15.97

mmol/l

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

116

0.69

0.36

2.3

1.6

—

(3008536) Aspergillus sp Ab [Presence] in Serum

189

1.22

0.36

2.4

2.3

—

(46236302) HLA-C [Type] by High resolution typing

1.43

0.35

1.0

—

(40760409) HLA-A [Type] by High resolution

1.43

0.35

1.0

—

(40760410) HLA-B [Type] by High resolution

1.43

0.35

1.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.43

0.35

2.0

9.2

98.50

105.69

g/l

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

427

0.87

0.35

1.2

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

427

0.87

0.35

1.2

1.5

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

208

1.20

0.35

1.2

1.3

56.95

53.15

0.16

175

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

126

1.27

0.35

1.0

1.1

—

(3013862) HLA-DP [Type]

1.40

0.35

1.0

—

(3052851) Hemolysis interference index of Serum or Plasma

234

2466

0.95

0.34

3.2

3.1

1.29

2.11

index

1.78

107

1283

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

372

0.86

0.33

1.0

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

740

0.90

0.33

1.2

1.1

25.41

19.34

u/ml

0.42

329

(3044007) Cell count panel - Peritoneal fluid

307

0.85

0.33

2.7

1.9

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.28

0.32

1.0

0.08

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

146

1.23

0.32

1.0

88.76

78.88

ug/l

0.30

119

(3026250) Tacrolimus [Mass/volume] in Blood

475

0.88

0.31

36.3

39.5

7.39

7.33

ug/l

0.08

429

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

523

1.11

0.30

1.3

1.1

—

(3017569) Oxygen content in Arterial blood

466

1.12

0.30

2.8

2.3

15.53

16.11

0.79

466

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

734

1.09

0.30

1.2

84.44

83.93

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

315

1.14

0.30

1.2

1200.00

1038.81

titre

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

842

1.08

0.29

1.3

1.4

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

139

1.22

0.29

1.9

1.6

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

112

1.25

0.28

1.5

1.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

586

0.90

0.28

1.6

1.7

—

(3001729) Color of Synovial fluid

1.29

0.28

1.4

1.3

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

183

0.82

0.27

2.1

3.5

82.94

126.68

ng/l

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

100

933

1.07

0.26

1.5

1.3

1.30

1.48

nmol/l

1.17

840

(44806420) Estimation of glomerular filtration rate

105

1121

0.94

0.26

2.6

2.3

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

0.67

0.25

3.2

2.5

0.80

0.59

u/field

—

(3025130) Human papilloma virus identified in Specimen

144

1520

0.95

0.25

1.9

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1454

14762

0.98

0.25

3.4

3.0

3.35

2.59

e6/l

1.37

806

6918

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

359

1.11

0.24

2.7

3.3

1.25

1.27

0.02

359

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

181

1894

0.95

0.23

1.7

1.5

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

568

0.92

0.23

1.4

1.5

7.03

5.98

u/l

0.37

462

(3020891) Body temperature

408

3964

1.03

0.23

4.5

4.6

36.92

36.91

°c

0.08

401

3932

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

510

5227

0.97

0.22

3.1

4.1

24.44

24.23

mmol/l

0.91

505

5172

(3050129) First trimester maternal screen panel - Serum or Plasma

226

2346

0.96

0.21

1.5

1.4

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.21

0.0

2.4

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

2984.50

—

(21494434) Karyotype in Bone marrow

778

1.07

0.21

1.3

1.2

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.21

0.0

7.8

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

829

8142

1.02

0.21

6.3

8.5

1.31

mmol/l

0.08

819

7999

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.21

0.0

1.3

—

(3029396) Erythrocyte agglutination [Presence] in Blood

211

1.14

0.20

2.7

2.9

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.20

0.0

1.4

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.20

0.0

1.1

—

(3051339) Copper [Moles/volume] in Blood

1.22

0.20

1.0

1.1

16.61

15.96

umol/l

—

(3000919) Neutrophils/Leukocytes in Pleural fluid

208

0.87

0.20

1.5

1.4

23.23

23.15

0.00

188

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

167

1602

1.04

0.20

1.3

1.2

3.06

3.17

u/ml

0.04

584

(3041806) Other cells [#/volume] in Blood by Manual count

229

0.87

0.20

1.5

0.49

0.50

e9/l

0.12

229

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.18

0.19

13.7

7.0

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

133

0.83

0.19

1.3

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

144

1378

1.05

0.19

1.1

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.15

0.19

1.0

1.1

9.31

8.21

mmol/l

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

101

959

1.05

0.18

1.0

1.3

—

(3010375) cycloSPORINE [Mass/volume] in Blood

434

1.08

0.18

30.6

28.7

124.78

114.51

ug/l

0.42

356

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

128

1.17

0.18

1.6

3.4

—

(3003577) Lead [Moles/volume] in Blood

100

1.20

0.18

1.1

1.4

0.21

0.19

umol/l

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

262

2543

1.03

0.18

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

454

1.08

0.18

2.4

2.0

8.29

8.07

mmol/l

0.16

454

(3047189) Immunofixation for 24 hour Urine

404

0.92

0.18

2.0

1.9

—

(3018405) Lactate [Moles/volume] in Arterial blood

277

2693

1.03

0.17

3.7

4.0

1.46

1.39

mmol/l

0.43

269

2645

(3010937) Rubella virus Ab [Presence] in Serum

1.13

0.17

1.0

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

494

5040

0.98

0.17

2.3

3.8

29.09

61.13

u/ml

4.31

473

4885

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

120

1.17

0.16

1.1

—

(3024928) Oxygen saturation in Venous blood

240

2332

1.03

0.16

3.2

64.33

62.93

0.48

232

2268

(43055442) Apixaban [Mass/volume] in Serum or Plasma

130

1.15

0.15

1.5

69.72

124.95

ug/l

—

111

(3011544) Albumin [Mass/volume] in Pleural fluid

0.76

0.15

1.2

1.1

21.85

18.48

g/l

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.21

0.15

1.2

1.1

83.20

103.33

titre

—

(21494814) CD8 cells/Lymphocytes in Specimen

390

1.08

0.15

1.7

2.1

26.86

31.03

1.16

390

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

390

1.08

0.15

1.9

2.1

158.33

184.72

ug/min

0.10

(3043409) Potassium [Moles/volume] in Arterial blood

231

2248

1.03

0.14

3.9

4.3

3.85

3.88

mmol/l

0.40

226

2229

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

1.18

0.14

1.5

1.6

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

208

2139

0.97

0.14

1.4

79.77

152.67

pmol/l

3.59

200

2083

(3051101) Glucose [Moles/volume] in Cord blood

122

1.15

0.13

4.2

6.0

8.23

7.80

mmol/l

0.18

122

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

171

1.11

0.12

1.0

1.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

191

1.10

0.11

1.2

1.8

2.04

2.23

ug/l

—

109

(3032868) Hemoglobin electrophoresis panel in Blood

1.16

0.11

1.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

603

1.05

0.10

6.6

7.2

9.31

70.08

ug/l

1.24

401

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.14

0.10

1.0

1.7

—

(3017509) Phencyclidine [Presence] in Urine

1.13

0.09

1.2

1.5

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

166

1695

0.98

0.08

1.5

1.6

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.82

0.08

1.0

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

226

0.93

0.08

1.5

1.7

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

542

5476

0.99

0.08

7.7

10.7

24.56

24.26

mmol/l

1.92

533

5391

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

160

1632

0.98

0.07

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

160

1632

0.98

0.07

1.3

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

215

1.07

0.07

1.1

1.2

76.00

72.00

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

347

0.95

0.07

3.2

3.5

6.87

8.22

mg/l

0.59

288

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1611

16034

1.01

0.07

3.3

2.9

1.11

1.28

e6/l

0.34

971

8254

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

191

1938

0.99

0.06

3.4

3.8

107.90

725.94

u/ml

3.23

172

1772

(3034426) Prothrombin time (PT)

334

0.96

0.05

1.4

1.2

26.59

28.28

1.84

334

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

232

0.95

0.05

1.5

1.3

2.51

277.94

ug/l

1.54

114

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

110

1119

0.98

0.04

2.5

2.4

17.11

23.88

iu/ml

0.43

115

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

189

1.06

0.04

1.4

1.18

1.17

mmol/l

0.23

189

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

219

1.05

0.04

1.1

1.2

105.00

78.37

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

775

0.98

0.04

1.1

1.2

346.67

247.82

titre

—

133

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

109

0.92

0.04

1.9

1.8

1.88

1.55

mg/l

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

114

1124

1.01

0.03

1.7

2.2

32.68

32.69

0.01

114

1118

(3051387) C reactive protein [Mass/volume] in Capillary blood

175

1732

1.01

0.03

4.0

3.2

27.56

27.18

mg/l

0.04

119

1181

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

103

1.07

0.02

1.0

1.1

—

(3036489) Thrombin time

364

3649

1.00

0.01

1.6

2.1

20.55

20.89

0.64

298

3212

(3050794) Legionella sp Ab [Presence] in Serum

1.06

0.01

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

116

0.95

0.00

1.2

1.6

—

(3009871) Measles virus Ab [Titer] in Serum

454

1.01

0.00

1.5

1.6

4204.44

3012.94

titre

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

784

1.01

0.00

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

557

1.01

0.00

1.0

0.16

1.17

u/ml

0.81

110

(40765096) Chromosome analysis panel by Banding

266

1.02

0.00

1.3

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

374

0.99

0.00

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

152

0.99

0.00

1.1

1.4

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

212

0.99

0.00

1.1

17.60

37.59

iu/ml

1.52

212

(3035880) pH of Pleural fluid

432

1.00

0.00

1.4

1.3

7.40

7.41

0.03

279

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

0.90

-0.00

1.1

1.7

13.34

20.75

pmol/l

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.90

-0.00

1.4

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

-0.00

0.0

1.0

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

341.00

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

14.00

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.9

—

28.07

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.95

-0.00

1.5

2.5

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.97

-0.00

1.0

1.1

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

-0.00

0.0

1.0

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

0.96

-0.00

1.0

—

14.10

—

(3009992) Blasts/cells in Bone marrow

0.00

-0.00

0.0

2.3

—

9.63

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

130

1.00

-0.00

1.4

1.3

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

19.20

—

(3020393) Adenovirus Ag [Presence] in Stool

0.93

-0.00

1.0

1.1

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

49.71

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.95

-0.00

1.0

1.1

—

0.22

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.91

-0.00

1.1

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.00

-0.00

1.2

1.1

—

(3012898) Urea [Moles/volume] in Urine

0.95

-0.00

1.1

1.5

194.33

174.36

mmol/l

—

(3042045) Bilirubin.total [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.2

—

92.50

—

Mortality – FinRegistry

↥

Association

Association between endpoint G6_ROOTPLEXOTHUNS and mortality.

Females

Parameter	HR [95% CI]	p-value
G6_ROOTPLEXOTHUNS	1.116 [1.01, 1.24]	0.034
Birth year	0.994 [0.99, 1.0]	0.182

During the follow-up period (1.1.1998 — 31.12.2019), 1878 out of 17306 females with G6_ROOTPLEXOTHUNS died.

Males

Parameter	HR [95% CI]	p-value
G6_ROOTPLEXOTHUNS	1.143 [1.03, 1.27]	0.011
Birth year	0.984 [0.98, 0.99]	0.001

During the follow-up period (1.1.1998 — 31.12.2019), 2262 out of 17987 males with G6_ROOTPLEXOTHUNS died.

Mortality risk

Mortality risk for people of age

years, who have G6_ROOTPLEXOTHUNS.

N-year risk	Females	Males
1	0.09%	0.202%
5	0.549%	1.193%
10	1.621%	2.904%
15	3.157%	5.689%
20	5.518%	9.527%

Relationships between endpoints

↥

Index endpoint: G6_ROOTPLEXOTHUNS – Other and unspecified nerve root and plexus disorders, also in other diseases

GWS hits: 3

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other and unspecified nerve root and plexus disorders, also in other diseases

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints